topic0
treatment [ftcn] 0.0100959189124
P NOS [aapp, imft] 0.00716429310304
Women [popg] 0.00593804917528
Study [mnob] 0.00584073994939
Age [orga] 0.00551670742878
Methods [inpr] 0.00462913586255
Group [idcn] 0.00436212070297
Cardiovascular disease [dsyn] 0.00421745743622
Increased [qnco] 0.00395042347991
Mortality [qnco] 0.00373697801774
Compared [acty] 0.00367403387808
Hypertension [dsyn] 0.00365982764627
Trial [resa] 0.00325233504301
Based [ftcn] 0.00315616256647
CARDIOVASCULAR [bdsy] 0.00311303542562
Conclusions [idcn] 0.00290846475589
radiotherapy [inpr] 0.00263808643001
months [tmco] 0.00263532051933
Cardiac [bpoc] 0.0025295869326
included [ftcn] 0.00252227947238
therapy [ftcn] 0.00249306110796
Management [ocac] 0.00239110596901
Survival [acty] 0.00228918454878
Health [idcn] 0.00225762376117
Including [ftcn] 0.00224079456448
effects [qlco] 0.00222872838686
Prevention [topp] 0.00219853698108
Evaluate [ftcn] 0.00211344147917
Men [popg] 0.00207474402965
Induced [ftcn] 0.00206571192877
Efficacy [qlco] 0.00202556110044
Cases [ftcn] 0.00201690531472
treated [topp] 0.0020081284409
Heart [bpoc] 0.00199868236254
Specific [qlco] 0.00194623537314
Suggest [idcn] 0.00187594435155
Performed [ftcn] 0.00185694938867
Diabetes [dsyn] 0.00184823868224
baseline [bodm] 0.00184651214933
IMPACT [gngm] 0.0018234797548
Observed [ftcn] 0.00181549266046
Stroke [dsyn] 0.00179060041402
Quality [qlco] 0.00177878357231
Assessed [acty] 0.00176485561095
High Risk [qlco] 0.00175540449496
Levels [qlco] 0.00175275375638
risk factors [qnco] 0.00172153652511
participants [popg] 0.00171980318745
Survivors [podg] 0.00170733468777
effective [qlco] 0.001654737771
Reserve [acty] 0.0016522551825
Dose [qnco] 0.00164436012609
Drug [phsu] 0.00164253436141
Reduced [qlco] 0.00163858193643
Hazard Ratio [qnco] 0.0016210781386
Severe [qlco] 0.0016057651627
Association [menp] 0.00158810548989
Therapeutic [topp] 0.00157232409122
N NOS [aapp, imft] 0.00156061563445
Complications [patf] 0.00151180091151
intervention [hlca] 0.00149557129497
Subject [grup] 0.00147563116658
Reported [inpr] 0.00145744563856
C-reactive protein [aapp, imft] 0.00145596570026
Evaluated [ftcn] 0.00144782659322
Adjusted [ftcn] 0.00144266505341
Care [acty] 0.00139962691367
Present [qnco] 0.00139783572719
Venous malformation [anab] 0.00138845720063
Blood Pressure [orgf] 0.00138814686978
Target [ftcn] 0.00137328023703
postmenopausal [tmco] 0.00136372160629
Myocardial Infarction [dsyn] 0.00134487900325
randomized [resa] 0.00133038350256
reduction [npop] 0.00132265142453
Hormone replacement therapy [topp] 0.00129801987105
Primary [qlco] 0.0012695679854
Medical [ftcn] 0.00126497259978
Aspirin [orch, phsu] 0.00125801995161
Main [qlco] 0.00125443139046
Identified [qlco] 0.0012431912548
Life [idcn] 0.00123442157406
Published [ocac] 0.00123431704588
coronary heart disease [dsyn] 0.00122924686568
Current [tmco] 0.00122831806237
Guidelines [inpr] 0.00122679822425
Improved [qlco] 0.00121736307041
Drug Therapy [topp] 0.0012090819459
Objective [inpr] 0.00120463580781
Statins [orch, phsu] 0.00120267369894
Design [acty] 0.00120255349525
placebo [topp] 0.00120240066247
practice [menp] 0.00119758180225
Independent [idcn] 0.00118335684049
Receive [qlco] 0.00117562882185
coronary artery disease [dsyn] 0.0011704529794
Combined [qlco] 0.00114452321625
Acute myocardial infarction [dsyn] 0.00113600626554
Heart failure [dsyn] 0.00112731166224
Received [qlco] 0.00111405383539
Following [tmco] 0.00110511327796
Decreased [qnco] 0.0011010245682
coronary [bpoc] 0.00109742412906
Likely [qlco] 0.00108437991807
Statin [orch, phsu] 0.00107727566492
Score [qnco] 0.00107709791366
Diagnosed [fndg] 0.00107160469115
Benefit [qnco] 0.00106973518729
symptoms [ftcn] 0.00106874985526
Prognostic Factor [clna] 0.00106485739159
Improvement [cnce] 0.00106146826504
Lipid [lipd] 0.00106042872872
Assessment [hlca] 0.00105622727697
Metabolic syndrome [dsyn] 0.00105180118192
Range [qnco] 0.00104799477479
Profile [lbpr] 0.00104337892116
Parameters [fndg] 0.00104077793635
Sclerotherapy [topp] 0.0010397701131
Authors [prog] 0.0010332718473
Estimated [qnco] 0.00102799607638
Mechanisms [ftcn] 0.00102744505102
Status [qlco] 0.00102214134105
ischaemic heart disease [dsyn] 0.00101780887362
condition [dsyn] 0.00101352604431
Available [ftcn] 0.00101342040315
Drugs [phsu] 0.00100744124084
interventions [hlca] 0.00100005840792
Atrial Fibrillation [patf] 0.000999814802958
Elderly [popg] 0.000999622590869
Surgery [bmod] 0.000995968341974
Chronic kidney disease [dsyn] 0.000992961999063
PREVENT [phsu] 0.000989215924265
findings [ftcn] 0.000984080308457
Old [tmco] 0.000983980538185
Breast Cancer [neop] 0.000981371592519
Medications [phsu] 0.000980435060585
considered [idcn] 0.000963097906941
Characteristics [qlco] 0.00095703520309
Radiation [npop] 0.000951037604294
Adherence [ftcn] 0.000949430180933
lesions [fndg] 0.000940289216582
People [popg] 0.000936994015749
Safety [hcpp] 0.00093012427076
Body Mass Index [diap] 0.000918201771875
Odds Ratio [qnco] 0.000912784199812
Sex [orgf] 0.000908184532014
acute [tmco] 0.000906724743244
Limited [ftcn] 0.000899998047842
Obesity [dsyn] 0.000890961006836
Approach [spco] 0.000886937084255
Irradiation [npop] 0.000873221237669
Well [qlco] 0.000871844841188
Issue [fndg] 0.000867017677659
Defined [cnce] 0.000865962704016
Estrogen [horm, phsu, strd] 0.00086116049819
Atherosclerosis [dsyn] 0.000858582557568
Combination [qlco] 0.00085745109792
Decrease [qlco] 0.000851974150355
Effectiveness [qlco] 0.000848738345642
Events [evnt] 0.000846784293852
Five [qnco] 0.000846452391381
Morbidity [qnco] 0.000846145931549
Evaluation [ftcn] 0.000846025367793
function [phsf] 0.000845881539704
society [orgt] 0.000845421057111
Purpose [ftcn] 0.000837275889543
strategy [menp] 0.000832877758364
Need [qlco] 0.000829769236066
search [inpr] 0.000829257143886
Cost Effectiveness [qnco] 0.000822220140659
Additional [ftcn] 0.000822085078318
vascular [bpoc] 0.000820899968365
Medication [phsu] 0.000817105414077
Small [qnco] 0.000807920046779
Make [ftcn] 0.000801732568975
Ratio [qnco] 0.000796794676612
Support [medd] 0.000787591044524
Conduct [inbe] 0.000786553137952
lowering [spco] 0.000784413544826
weeks [tmco] 0.000782524901659
cardiovascular risk factor [dsyn] 0.000780760043225
Index [inpr] 0.000779175522021
rats [mamm] 0.000777299238088
deaths [orgf] 0.000776750019417
History [ocdi] 0.000775651049189
LTD [ortf] 0.000775289580271
In [qnco] 0.000774227411901
Known [qlco] 0.000773202298668
Large [qnco] 0.000772368263689
Established [qlco] 0.000770964955411
Controlled [ftcn] 0.000769150794418
Physical activity [dora] 0.000768983417877
Burden [idcn] 0.000766528227746
Damage [inpo] 0.000764216353018
recommendations [idcn] 0.000761809805403
Adults [aggp] 0.000761331669125
Several [qnco] 0.000761167548839
APPEAR [qlco] 0.000759890218637
national [inpr] 0.000759196516974
Recently [tmco] 0.000756914304217
Agent [chvf] 0.000755063383056
Physicians [prog] 0.000749792207007
Multiple [qnco] 0.000748455529301
Moderate [qlco] 0.000744844253196
Children [aggp] 0.000743121932483
strategies [menp] 0.00074287088567
Female [fndg] 0.000733688989668
System [ftcn] 0.000728363686794
Report [inpr] 0.000728361132095
Functional [ftcn] 0.000727767542303
Relationship [qlco] 0.000727443564171
Previous [tmco] 0.000717918882375
mg% [qnco] 0.000716993791577
Database [inpr] 0.000716349780232
Contribute [acty] 0.000714690444908
GY [geoa] 0.000711986314157
Comorbidities [idcn] 0.000711617432509
Needed [qlco] 0.000710221872516
chronic [tmco] 0.000706928303118
With [qlco] 0.000706804655587
Cardiovascular Diseases [dsyn] 0.00070499692199
Tool [mnob] 0.000704502072691
???lead [elii, hops] 0.000697758300727
Article [inpr] 0.000696087702374
Vascular Malformations [anab] 0.000686425767989
Appropriate [qlco] 0.000683620374371
Measured [qlco] 0.000682457052051
Oral [spco] 0.000682119181949
Area [geoa] 0.000681759824429
Select [acty] 0.000679457406003
cardiovascular events [fndg] 0.000678706556268
Lung Cancer [neop] 0.000677650695111
Various [irda] 0.000675983394366
Complex [qlco] 0.000675750254479
Presented [idcn] 0.000674828495429
Average [qnco] 0.000672838874048
Currently [tmco] 0.000669061997287
Beta-Blockers [phsu] 0.000668299289693
Single [popg] 0.000668213966232
Segment [spco] 0.00066818394038
hypertensive [fndg] 0.000667278144733
investigate [ftcn] 0.000665107898953
progression [patf] 0.000664387104416
Initial [tmco] 0.000659976933872
Dyslipidaemia [dsyn] 0.000656803405718
activity [dora] 0.000655349656167
Recommended [idcn] 0.000654412131219
Affect [menp] 0.000653888270083
Heart disease [dsyn] 0.000653120668752
Part [spco] 0.00065265564652
Optimal [qlco] 0.000652397445709
Therapies [topp] 0.000651778526674
Imaging [diap] 0.000648231327482
Of [spco] 0.000647733688339
Novel [tmco] 0.000647152456658
GIVEN [cnce] 0.000645878178289
Guide [prog] 0.00064484252506
Standard [qlco] 0.000636359579668
days [tmco] 0.000632075453695
Information [idcn] 0.000629677364221
Antioxidant [phsu] 0.000629437196259
Local [spco] 0.00062594792897
Diseases [dsyn] 0.000620134212586
Address [inpr] 0.000617051735824
Late [tmco] 0.000616721965298
Values [qlco] 0.000612819014121
adverse events [fndg] 0.000612761036446
Regression [patf] 0.000611745523074
PLAN [dsyn] 0.000611323668306
Often [tmco] 0.000611258902244
objectives [inpr] 0.000611149884112
lack [qlco] 0.000610844752884
Smoking [inbe] 0.000607897457315
Long [qlco] 0.00060736148603
Ischaemic [ftcn] 0.000606810527324
Comparison [acty] 0.000606393075088
Secondary Prevention [topp] 0.000605719760443
Last [qlco] 0.000603722079862
Depression [mobd] 0.000602761318268
Young [tmco] 0.000602244268218
mmHg [qnco] 0.000600968531959
Prostate Cancer [neop] 0.000600226772413
investigated [ftcn] 0.000599248658231
Reducing [qlco] 0.000591582775783
Hospital [hcro, mnob] 0.000588684710395
Program [cnce] 0.000587492341781
Negative [qlco] 0.00058679178247
Marker [clna] 0.000584383120899
Clinic [hcro, mnob] 0.000582947676071
Life Style [socb] 0.000580858549235
Update [tmco] 0.000579968681814
Risks [qlco] 0.000574392570025
Increasing [ftcn] 0.000574384469518
majority [socb] 0.000573730779205
Proportion [qnco] 0.000573716005871
Adult [aggp] 0.000573268765024
Duration [tmco] 0.000572962869121
Doses [qnco] 0.000571883020379
Prescription [hlca] 0.000570458536674
Link [inpr] 0.00056954574879
Addition [ftcn] 0.000569246239497
Confidence Intervals [qnco] 0.000568284034598
Understanding [menp] 0.000568022004036
Occurred [acty] 0.000567658865492
Literature [inpr] 0.000567367530039
prognostic [inpr] 0.000566600879441
M NOS [aapp, imft] 0.000566275396835
Bleeding [patf] 0.000563710853456
Take [hlca] 0.000563559164074
Registry [inpr] 0.000562744680569
Androgen Deprivation Therapy [topp] 0.000562067948738
Aged [orga] 0.000561564728534
Treatments [topp] 0.000560949076056
Seven [qnco] 0.000559254083237
Exercise [dora] 0.000557726745906
Colorectal Cancer [neop] 0.000557133519405
Surgical [hlca] 0.000555886526498
Oxidative Stress [comd] 0.000552999366631
High Density Lipoprotein Cholesterol [bacs, lipd] 0.000552551683642
mg dl [qnco] 0.000551413881659
Plasma [bdsu] 0.000549733883403
Complete [qlco] 0.000545320543067
Post [tmco] 0.000543692248242
Concern [idcn] 0.000543573129887
Central [spco] 0.000543399836854
Form [qlco] 0.000542403947596
Measures [qnco] 0.000541949691658
Control Group [grup] 0.000540232305287
Diet [food] 0.000537719356133
Activation [acty] 0.000537616917337
side effects [ftcn] 0.000535642541987
Collected [idcn] 0.00053429943919
Improving [qlco] 0.000534086478389
Examined [fndg] 0.000534086025861
Cardiology [bmod] 0.000533790286927
H+ [elii] 0.000533063554437
Alone [qnco] 0.000532287471012
Calculated [ftcn] 0.000531791096668
Decade [qnco] 0.000531221892001
Menopause [phsf] 0.000530198772243
Ischaemic stroke [dsyn] 0.000528135406175
Hormone Therapy [topp] 0.000527552501634
Regular [qlco] 0.000527548024494
Six [qnco] 0.000526834225618
Benefits [qnco] 0.000524725437142
variables [qlco] 0.000523411853266
Application [hlca] 0.000522962653282
Represent [acty] 0.00052211373898
Associations [menp] 0.000519498140062
Endothelial [tisu] 0.00051870145274
Future [tmco] 0.000517257636241
Hospitalization [hlca] 0.000516972415629
Onset [qlco] 0.000513279760821
Required [ftcn] 0.000512715278285
Bias [idcn] 0.000510627898089
experience [menp] 0.000510303485243
Process [bpoc] 0.00050996073953
Consecutive [qlco] 0.000507964501196
Diabetes Mellitus [dsyn] 0.000504361408974
prospective [resa] 0.000502282901959
Elevated [qlco] 0.000502006466221
Chemotherapy [topp] 0.000501973523682
patient care [hlca] 0.000501318150421
Severity [qlco] 0.000501027216831
Meta-Analysis [inpr] 0.000500801180187
Seen [qlco] 0.000497735972948
Administered [ftcn] 0.000495760185664
Inflammation [patf] 0.00049161821568
Females [fndg] 0.000491606471949
reviewed [inpr] 0.000490333933908
secondary [neop] 0.000489504804946
Cholesterol [bacs, strd] 0.000487982673706
Searched [acty] 0.000487768292404
Echocardiography [diap] 0.000486893758149
Extracted [topp] 0.000483478199558
Head [blor] 0.000479939668858
Alternative [cnce] 0.000479822204675
Value [qnco] 0.000478254144671
properties [qlco] 0.000476784133226
statistically significant [qnco] 0.000476741103742
Approaches [spco] 0.000476677702692
Countries [geoa] 0.000473403386656
Center [spco] 0.00047161125774
Test [lbpr] 0.000471552172552
Percutaneous [spco] 0.000471172437751
Complication [patf] 0.00047029385931
setting [ftcn] 0.000468668500475
Exist [cnce] 0.000466218627561
Exposure NOS [inpo] 0.00046585204014
Congenital heart disease [cgab, dsyn] 0.00046439980372
Measure [qnco] 0.000462241784801
Active [ftcn] 0.000461353619682
Metabolic [ftcn] 0.00046066339421
Correlated [qlco] 0.000459934255256
Venous Thromboembolism [patf] 0.000458933694157
Gender [orga] 0.00045816126793
Indicated [fndg] 0.000458014770425
Review, Systematic [inpr] 0.000457526327652
Community [geoa] 0.000457063477418
Awareness [menp] 0.000455896283827
topic1
treatment [ftcn] 0.00992294354905
P NOS [aapp, imft] 0.00858823132041
Study [mnob] 0.0064601735276
Compared [acty] 0.00585911249222
Mortality [qnco] 0.0055069285451
Age [orga] 0.00528489426934
Women [popg] 0.00483323292968
Cardiovascular disease [dsyn] 0.00478874477283
Methods [inpr] 0.0043464886848
Group [idcn] 0.0043016221262
Increased [qnco] 0.00379789789745
Trial [resa] 0.00344947996791
Conclusions [idcn] 0.00321309834329
CARDIOVASCULAR [bdsy] 0.00298535035855
therapy [ftcn] 0.0029712722609
Hypertension [dsyn] 0.00287731322005
Based [ftcn] 0.00259522755052
Stroke [dsyn] 0.00259099016919
Diabetes [dsyn] 0.00258493982073
Survival [acty] 0.00250018195807
included [ftcn] 0.00241717373477
radiotherapy [inpr] 0.00240540920797
Prevention [topp] 0.00230098734657
Health [idcn] 0.00227233846845
Efficacy [qlco] 0.00221879511932
N NOS [aapp, imft] 0.00220718252288
effects [qlco] 0.00209628220088
Including [ftcn] 0.00197582619567
Association [menp] 0.0019378863646
Suggest [idcn] 0.00191165273079
Levels [qlco] 0.00191152915599
Dose [qnco] 0.00190139328643
Performed [ftcn] 0.00188392307967
treated [topp] 0.00185468563146
Old [tmco] 0.00182530378115
Heart [bpoc] 0.00181434833569
Assessed [acty] 0.00180589256864
risk factors [qnco] 0.00179063125274
Present [qnco] 0.00177193348971
High Risk [qlco] 0.0017644380851
Cases [ftcn] 0.00175770329902
Complications [patf] 0.00174916039136
IMPACT [gngm] 0.00174628617168
Quality [qlco] 0.00168107666627
Reserve [acty] 0.00167495381235
postmenopausal [tmco] 0.00166887487994
Management [ocac] 0.00161707775535
Myocardial Infarction [dsyn] 0.00159890589334
Observed [ftcn] 0.00157054996546
months [tmco] 0.00156204597231
Prognostic Factor [clna] 0.00155667844022
Men [popg] 0.00149794922799
Body Mass Index [diap] 0.00148074249164
effective [qlco] 0.00145900264046
reduction [npop] 0.00145595474983
Blood Pressure [orgf] 0.00145349467307
Received [qlco] 0.00145175065668
coronary artery disease [dsyn] 0.00144613570947
baseline [bodm] 0.00143282162742
Cardiac [bpoc] 0.00143140446725
Care [acty] 0.00142767844426
Severe [qlco] 0.00139887965275
Induced [ftcn] 0.00139879066515
Primary [qlco] 0.00138731287893
Objective [inpr] 0.00137994676944
Hazard Ratio [qnco] 0.00137813113831
placebo [topp] 0.00137741959763
Target [ftcn] 0.0013457320398
Hormone replacement therapy [topp] 0.00132949120171
Evaluate [ftcn] 0.0013126124236
Reduced [qlco] 0.00130887775878
Improvement [cnce] 0.00130780294179
Statins [orch, phsu] 0.00130379659401
Reported [inpr] 0.00129094326886
Surgery [bmod] 0.0012663300117
Current [tmco] 0.001248983491
coronary heart disease [dsyn] 0.00124478550414
coronary [bpoc] 0.00124417258134
participants [popg] 0.00124171275401
Need [qlco] 0.00124117807463
Atrial Fibrillation [patf] 0.00123779665667
Range [qnco] 0.00123127011245
Identified [qlco] 0.00121851862011
interventions [hlca] 0.00121314426309
cardiovascular events [fndg] 0.00120325028261
Acute myocardial infarction [dsyn] 0.00120085595639
Drug [phsu] 0.00117879385179
Decreased [qnco] 0.0011741560758
condition [dsyn] 0.00116308771844
Evaluated [ftcn] 0.0011557252955
Design [acty] 0.00115540954294
Survivors [podg] 0.00115403274205
Atherosclerosis [dsyn] 0.00115059177414
Large [qnco] 0.00114912095101
Effectiveness [qlco] 0.0011443702351
practice [menp] 0.00113919901256
Sclerotherapy [topp] 0.00112922768116
Chronic kidney disease [dsyn] 0.00112066912552
Benefit [qnco] 0.0011162966547
Heart failure [dsyn] 0.00111412941848
Specific [qlco] 0.00111273921096
Parameters [fndg] 0.00110601960126
Therapeutic [topp] 0.00110189173395
Lipid [lipd] 0.00110064839872
findings [ftcn] 0.00110001679219
Morbidity [qnco] 0.00109675591874
Controlled [ftcn] 0.00109514310145
randomized [resa] 0.00109084503726
Available [ftcn] 0.00108880980222
Guidelines [inpr] 0.0010856035032
Breast Cancer [neop] 0.00108378753767
C-reactive protein [aapp, imft] 0.00107978714558
Drug Therapy [topp] 0.0010735854747
Main [qlco] 0.00106664813615
Index [inpr] 0.00106585265045
Conduct [inbe] 0.00105442887921
intervention [hlca] 0.00105199773047
strategies [menp] 0.00104900344598
Purpose [ftcn] 0.00104593405361
Children [aggp] 0.00101871256538
Score [qnco] 0.00101618847606
Subject [grup] 0.00101338073273
Independent [idcn] 0.00101325271103
PREVENT [phsu] 0.00100948908365
Irradiation [npop] 0.00100679009681
GY [geoa] 0.00100517225132
setting [ftcn] 0.00100301847369
Radiation [npop] 0.000999938088954
Often [tmco] 0.000995150302535
Improved [qlco] 0.000993890508174
Combination [qlco] 0.000993635195574
Elderly [popg] 0.000991451217716
Medical [ftcn] 0.000977189665723
Decrease [qlco] 0.000975726525617
Profile [lbpr] 0.000975070120992
Odds Ratio [qnco] 0.000974440229512
Life [idcn] 0.000957418669415
Small [qnco] 0.000945033362917
Receive [qlco] 0.000943172819697
Authors [prog] 0.000942817366861
Measured [qlco] 0.000938276949753
Established [qlco] 0.000932320188633
objectives [inpr] 0.000928077465918
experience [menp] 0.0009236700176
Article [inpr] 0.000912271446358
Young [tmco] 0.000908235000327
Additional [ftcn] 0.000907235523302
Values [qlco] 0.000905935039441
Required [ftcn] 0.000903076134643
Venous malformation [anab] 0.00090221382603
Following [tmco] 0.000902212021393
Statin [orch, phsu] 0.00090144099832
Safety [hcpp] 0.000901153241667
Drugs [phsu] 0.000899197971366
Androgen Deprivation Therapy [topp] 0.000892666680818
Evaluation [ftcn] 0.000891103342931
Life Style [socb] 0.000884737327044
Adherence [ftcn] 0.000883259740265
acute [tmco] 0.000880730600386
People [popg] 0.000879236975941
Published [ocac] 0.000870168661837
Treatments [topp] 0.000867003800497
progression [patf] 0.000864463570764
considered [idcn] 0.000860877193944
Ratio [qnco] 0.0008597634885
Previous [tmco] 0.000859052575419
Examined [fndg] 0.000859017302939
Mechanisms [ftcn] 0.000857944021994
investigated [ftcn] 0.000848307656076
Combined [qlco] 0.00084592654091
vascular [bpoc] 0.000843837791999
search [inpr] 0.000842897974019
weeks [tmco] 0.000842697366822
national [inpr] 0.000840518876138
Known [qlco] 0.000838877061083
Metabolic syndrome [dsyn] 0.000837324921274
Make [ftcn] 0.000834227548874
Literature [inpr] 0.0008331694547
Vascular Malformations [anab] 0.000830872049491
Update [tmco] 0.000829541878605
Assessment [hlca] 0.000829503182128
Adults [aggp] 0.000825016710469
Diagnosed [fndg] 0.000820425447714
Well [qlco] 0.000817845518099
lowering [spco] 0.000815336612926
strategy [menp] 0.000804948286837
Female [fndg] 0.000802783827183
Novel [tmco] 0.000801461918749
Future [tmco] 0.000800798552738
Information [idcn] 0.000800605766794
Report [inpr] 0.000784248114128
days [tmco] 0.000782865150006
symptoms [ftcn] 0.000781398061651
hypertensive [fndg] 0.000780851258863
mg dl [qnco] 0.000780296123933
???lead [elii, hops] 0.000779867144776
H+ [elii] 0.000779738728284
Functional [ftcn] 0.000769363221449
Single [popg] 0.000761171044071
Heart disease [dsyn] 0.000759890619684
Agent [chvf] 0.000757234283563
Aspirin [orch, phsu] 0.000757133416427
Characteristics [qlco] 0.000755828031973
Obesity [dsyn] 0.000753831117313
LTD [ortf] 0.000752693128068
Dyslipidaemia [dsyn] 0.000752671095441
Oral [spco] 0.000750872322004
Adjusted [ftcn] 0.000749893316996
Sex [orgf] 0.000749587195312
Initial [tmco] 0.000748805978443
Local [spco] 0.00073832378446
Approach [spco] 0.000737651622646
Limited [ftcn] 0.00072924513548
History [ocdi] 0.000728874902795
Medication [phsu] 0.000724699402173
Prescription [hlca] 0.000724155587993
Damage [inpo] 0.000724052150175
GIVEN [cnce] 0.000722293119028
Several [qnco] 0.000721478837435
M NOS [aapp, imft] 0.000721421421784
Defined [cnce] 0.000721339497971
Estimated [qnco] 0.00071571039649
In [qnco] 0.000715135356808
Likely [qlco] 0.000712248614236
Cost Effectiveness [qnco] 0.000711539708999
Improving [qlco] 0.000710427601212
Beta-Blockers [phsu] 0.00070676926364
Response [orga] 0.00070270437108
Marker [clna] 0.000701145940102
Imaging [diap] 0.000699613225555
Alone [qnco] 0.00069945588427
Comorbidities [idcn] 0.00069712780997
Support [medd] 0.000693056164366
function [phsf] 0.000686118228058
Benefits [qnco] 0.00068558616711
Moderate [qlco] 0.000683047086009
Multiple [qnco] 0.000679045967141
Surgical [hlca] 0.000677339337386
Issue [fndg] 0.000675355274366
Cardiovascular Diseases [dsyn] 0.000673547400179
Recommended [idcn] 0.00067334102572
Comparison [acty] 0.000672963879591
Endothelial [tisu] 0.000672706552753
Status [qlco] 0.000671552857004
Medications [phsu] 0.000668390449961
chronic [tmco] 0.000666981641831
Indicated [fndg] 0.000666717463822
Select [acty] 0.000665896005311
Diseases [dsyn] 0.000665543218272
Obtained [ftcn] 0.000664347892104
Sample [sbst] 0.000664038463577
Calculated [ftcn] 0.000663076924526
Aged [orga] 0.000660102382167
rats [mamm] 0.000660043576713
Post [tmco] 0.000658403535743
society [orgt] 0.000653598371081
Estrogen [horm, phsu, strd] 0.000653219767114
secondary [neop] 0.000650579739496
Last [qlco] 0.000648775881752
Diabetes Mellitus [dsyn] 0.000645472948248
Needed [qlco] 0.000643130844543
Increasing [ftcn] 0.000642555707047
Six [qnco] 0.000642413297602
Events [evnt] 0.000638661737072
Complex [qlco] 0.000626040261628
lesions [fndg] 0.000622762376708
Contribute [acty] 0.000621403240871
Smoking [inbe] 0.000620234301658
Central [spco] 0.000617004990496
variables [qlco] 0.000615598805245
investigate [ftcn] 0.000615522873229
Exercise [dora] 0.000614702509901
Activation [acty] 0.000613042230089
Acute Coronary Syndrome [dsyn] 0.000612575476521
Hospitalization [hlca] 0.000612527127526
mmHg [qnco] 0.000607345727173
Plasma [bdsu] 0.000607115054065
Proportion [qnco] 0.000604853768277
Burden [idcn] 0.000604853440924
Pain [sosy] 0.000602969010914
Represent [acty] 0.000600919499053
Take [hlca] 0.000599597073231
Appropriate [qlco] 0.000599456025709
Countries [geoa] 0.000598396176801
reviewed [inpr] 0.00059685036396
adverse events [fndg] 0.000595266450115
Secondary Prevention [topp] 0.000594216098195
Average [qnco] 0.000592417571705
Currently [tmco] 0.000592128217224
Confidence Intervals [qnco] 0.000591775650308
Hospital [hcro, mnob] 0.000590761172604
Adult [aggp] 0.000590680610606
Long [qlco] 0.00059023610455
Guide [prog] 0.000589436279117
Cost [qnco] 0.000584142876763
With [qlco] 0.000583969597525
Standard [qlco] 0.000583736986692
cardiovascular risk factor [dsyn] 0.000581553606472
activity [dora] 0.000579553106377
Duration [tmco] 0.000574244134356
Risks [qlco] 0.000573271817386
mg% [qnco] 0.000571702381269
Interaction [ftcn] 0.000570202015597
Exposure NOS [inpo] 0.000569887963312
Physical activity [dora] 0.0005694950194
Relationship [qlco] 0.000568717876353
Menopause [phsf] 0.000568687235479
Database [inpr] 0.000567698730786
Optimal [qlco] 0.000564471868073
Link [inpr] 0.000562957686889
Late [tmco] 0.000562052715498
Doses [qnco] 0.000560265029461
divided [ftcn] 0.000559460466237
Associations [menp] 0.000558700001121
deaths [orgf] 0.000557879108481
Occurred [acty] 0.000556076388419
System [ftcn] 0.000555525258416
Symptomatic [ftcn] 0.000554291798305
Depression [mobd] 0.00055125605933
Risk Ratios [qnco] 0.000550825024231
Various [irda] 0.000550313893634
Action [ftcn] 0.000547339124266
Altered [ftcn] 0.000533826062965
Addition [ftcn] 0.000532006181921
Colorectal Cancer [neop] 0.000529975733294
Term [tmco] 0.000529002320408
Active [ftcn] 0.00052866917971
Seen [qlco] 0.000527778448214
Reducing [qlco] 0.000527189556203
Oxidative Stress [comd] 0.000524888270386
Meta-Analysis [inpr] 0.000523978938426
Revealed [qlco] 0.000523710202225
Renal [bpoc] 0.000523173385133
Physicians [prog] 0.000520993807202
Approaches [spco] 0.00051962729447
R- [spco] 0.000518138685002
Five [qnco] 0.000513416790076
Dependent [qlco] 0.000512364054954
Focus [spco] 0.000511889047435
Extract [sbst] 0.000511750127682
Ageing [orgf] 0.000509929744569
statistically significant [qnco] 0.000509348162939
Elevated [qlco] 0.000508705582715
Monitoring [hlca] 0.000507692209374
Scale [medd] 0.00050757379155
measurements [ftcn] 0.000507489090262
Bleeding [patf] 0.000505857023576
Leading [tmco] 0.000502984248578
Cardiology [bmod] 0.000500274617256
Ischaemic [ftcn] 0.000497714085763
Test [lbpr] 0.000496984871764
Compound [qlco] 0.000496650426223
Alternative [cnce] 0.000495451478777
ischaemic heart disease [dsyn] 0.000495156405893
Systolic blood pressure [clna] 0.000494207967659
Registry [inpr] 0.000493889631681
Presented [idcn] 0.000490480303997
surveillance [ftcn] 0.000490353643283
Ischaemic stroke [dsyn] 0.000490237906438
prognostic [inpr] 0.000488910728236
Affect [menp] 0.000488879264013
Community [geoa] 0.000488003190605
High dose [qnco] 0.000486688813987
Searched [acty] 0.000486666831225
Diet [food] 0.000485057128027
size [spco] 0.000484604198449
Antioxidant [phsu] 0.000484446199328
Tool [mnob] 0.000478077090341
Regression [patf] 0.000477982923077
Total Cholesterol [lbpr] 0.00047757242189
Administered [ftcn] 0.000477519119058
APPEAR [qlco] 0.000476765165437
Niacin [orch, phsu, vita] 0.000476348088868
Prostate Cancer [neop] 0.000475788435796
Part [spco] 0.000475455230981
Understanding [menp] 0.000473684304275
Relative [famg] 0.000472744503199
Of [spco] 0.000471544315516
Glomerular Filtration Rate [diap] 0.000470482838042
Pregnancy [orgf] 0.000470380866983
Address [inpr] 0.000469429775552
HIV [virs] 0.00046900479955
Arterial [bpoc] 0.000468744257781
Knowledge [inpr] 0.00046751725908
Inflammation [patf] 0.000466856265302
Measures [qnco] 0.000466611408946
Control Group [grup] 0.000465309850488
prospective [resa] 0.000464531080198
Estimate [qnco] 0.000464469243872
Therapies [topp] 0.000463051628555
High Density Lipoprotein Cholesterol [bacs, lipd] 0.000462623349046
Program [cnce] 0.000460078760302
Order [inpr] 0.000459609648286
procedures [inpr] 0.000459490671025
Affected [ftcn] 0.000459040474482
Human [humn] 0.000457379226798
Hormone Therapy [topp] 0.000456761441007
Relevant [qlco] 0.000456678834477
recommendations [idcn] 0.000454032270677
Gender [orga] 0.000452437748289
topic2
treatment [ftcn] 0.0105837156405
P NOS [aapp, imft] 0.00743705138664
Study [mnob] 0.00693674834324
Group [idcn] 0.0060178815135
Women [popg] 0.00563995683677
Compared [acty] 0.00436607237405
Conclusions [idcn] 0.00413030940036
Age [orga] 0.00411392321971
Cardiovascular disease [dsyn] 0.00393890402905
Increased [qnco] 0.00385331265615
effects [qlco] 0.00353580301185
Hypertension [dsyn] 0.00352456913215
Mortality [qnco] 0.00344064093023
Trial [resa] 0.00328435649534
Methods [inpr] 0.00326086198644
Based [ftcn] 0.00310382400241
CARDIOVASCULAR [bdsy] 0.00309575319419
therapy [ftcn] 0.00292417498116
Cardiac [bpoc] 0.00258188977631
Diabetes [dsyn] 0.00256419928608
months [tmco] 0.00252607401363
treated [topp] 0.00252355842291
participants [popg] 0.00245259225909
Survival [acty] 0.00242721752561
radiotherapy [inpr] 0.0021972565221
Stroke [dsyn] 0.00218638388344
Men [popg] 0.00218376597001
included [ftcn] 0.00218176713179
Hormone replacement therapy [topp] 0.00208448078439
Heart [bpoc] 0.00207131367614
Levels [qlco] 0.00193531384322
N NOS [aapp, imft] 0.00191866299066
Suggest [idcn] 0.0019159026608
Objective [inpr] 0.00186455300381
reduction [npop] 0.00184075559239
Health [idcn] 0.00183214596236
coronary heart disease [dsyn] 0.00181142819419
Performed [ftcn] 0.0018107358896
risk factors [qnco] 0.00180937758491
Dose [qnco] 0.0017449956473
Blood Pressure [orgf] 0.00173843449156
Management [ocac] 0.00173266223411
Including [ftcn] 0.00169177371094
Induced [ftcn] 0.00166634053781
Specific [qlco] 0.00165774787324
Cases [ftcn] 0.00163829932162
Assessed [acty] 0.00163134414342
effective [qlco] 0.00159165966739
Published [ocac] 0.00158783391376
Breast Cancer [neop] 0.001555143887
Reported [inpr] 0.00152542324873
Complications [patf] 0.00152118570932
Survivors [podg] 0.00152117256751
postmenopausal [tmco] 0.00152101190665
Prevention [topp] 0.00150666551936
Present [qnco] 0.00149649817584
Quality [qlco] 0.00146766731057
Approach [spco] 0.00146678815299
Observed [ftcn] 0.00146627908752
Reserve [acty] 0.00146445336224
Care [acty] 0.00143616596907
Reduced [qlco] 0.00143163435529
Prognostic Factor [clna] 0.00142814982477
Hazard Ratio [qnco] 0.00142683791979
Received [qlco] 0.00142104540475
Evaluated [ftcn] 0.00141396150247
Old [tmco] 0.00140788043037
coronary artery disease [dsyn] 0.00139969385539
Main [qlco] 0.00134793267044
randomized [resa] 0.00134244973563
Receive [qlco] 0.00133829167284
PREVENT [phsu] 0.0013363456162
Efficacy [qlco] 0.00133344746003
baseline [bodm] 0.00132799696189
Lipid [lipd] 0.00132486466794
considered [idcn] 0.00132339912446
Myocardial Infarction [dsyn] 0.00131563249875
IMPACT [gngm] 0.00129549885047
Guidelines [inpr] 0.00129279956343
Target [ftcn] 0.00128697541859
intervention [hlca] 0.00128522992859
Heart failure [dsyn] 0.00128129017497
placebo [topp] 0.00128033446365
Design [acty] 0.00128011775197
Evaluate [ftcn] 0.00127695991324
Purpose [ftcn] 0.00126472092302
Surgery [bmod] 0.00124907721746
Association [menp] 0.00124525738984
Statin [orch, phsu] 0.00123905165448
Identified [qlco] 0.00122880928545
Children [aggp] 0.00122228386363
Therapeutic [topp] 0.0012119203226
symptoms [ftcn] 0.00120589018091
Atrial Fibrillation [patf] 0.00120430950023
Controlled [ftcn] 0.00119230405011
Range [qnco] 0.0011894294331
Improvement [cnce] 0.00118392502189
Current [tmco] 0.00118172664282
Subject [grup] 0.00117516101056
findings [ftcn] 0.00117113715502
Life [idcn] 0.00116133143973
Metabolic syndrome [dsyn] 0.00115826708262
search [inpr] 0.001112899331
vascular [bpoc] 0.00110988622919
Benefit [qnco] 0.00110755317212
Support [medd] 0.00110331315671
hypertensive [fndg] 0.00110135026173
Statins [orch, phsu] 0.00109686499376
Adherence [ftcn] 0.00109333717573
Estrogen [horm, phsu, strd] 0.00108752336114
cardiovascular events [fndg] 0.0010778479557
Drug [phsu] 0.0010714089159
Sclerotherapy [topp] 0.00106667899826
condition [dsyn] 0.00103766480828
setting [ftcn] 0.00102669443253
High Risk [qlco] 0.00102539003444
Additional [ftcn] 0.00101552561786
Acute myocardial infarction [dsyn] 0.00101238323885
Obesity [dsyn] 0.00101204859821
Following [tmco] 0.00101102051655
Odds Ratio [qnco] 0.00100985268654
Often [tmco] 0.0010090971722
Events [evnt] 0.000997760117636
Examined [fndg] 0.000995842775799
weeks [tmco] 0.000995796820721
Combined [qlco] 0.000988300925802
Atherosclerosis [dsyn] 0.00098827272965
Available [ftcn] 0.000987771478665
Improved [qlco] 0.000986658050649
Decreased [qnco] 0.000981544906386
coronary [bpoc] 0.000981494719109
Optimal [qlco] 0.000981412695383
objectives [inpr] 0.000972844732186
Safety [hcpp] 0.000970552988369
Profile [lbpr] 0.000967546669512
Future [tmco] 0.000966736167711
Aspirin [orch, phsu] 0.000966624840739
Authors [prog] 0.000966522695576
History [ocdi] 0.000965880065617
interventions [hlca] 0.000965623608192
practice [menp] 0.00096079558154
Need [qlco] 0.000952956916465
Radiation [npop] 0.000950817928057
Decrease [qlco] 0.000949849835891
Parameters [fndg] 0.000944042312246
Update [tmco] 0.000942556861753
Five [qnco] 0.000940567901766
Combination [qlco] 0.00094040624765
Diagnosed [fndg] 0.00093397130076
Drugs [phsu] 0.000932967416053
Literature [inpr] 0.000920080273115
Independent [idcn] 0.000917885516794
Multiple [qnco] 0.000915707597743
LTD [ortf] 0.000907521089229
Large [qnco] 0.000907093889113
Drug Therapy [topp] 0.000904475824144
Effectiveness [qlco] 0.000902862923822
Chronic kidney disease [dsyn] 0.000899390107917
Conduct [inbe] 0.000891186017929
GY [geoa] 0.000891053537132
Issue [fndg] 0.00088942043995
Characteristics [qlco] 0.000881780363173
People [popg] 0.000881418733186
Complex [qlco] 0.00087270238071
Elderly [popg] 0.000870054356194
ischaemic heart disease [dsyn] 0.000868503131791
Venous malformation [anab] 0.000864664666818
rats [mamm] 0.000863170177143
Make [ftcn] 0.000862226405405
Medical [ftcn] 0.000854837507776
Physical activity [dora] 0.000853827519959
Primary [qlco] 0.000845582308342
Measured [qlco] 0.000844397617397
Diabetes Mellitus [dsyn] 0.000841203479633
Adjusted [ftcn] 0.000835770082563
Article [inpr] 0.000834647696364
Values [qlco] 0.000826454968107
Established [qlco] 0.000823376162153
M NOS [aapp, imft] 0.000818236111022
chronic [tmco] 0.000818085200622
APPEAR [qlco] 0.000814264349215
???lead [elii, hops] 0.000812103504656
Several [qnco] 0.00080554449608
Body Mass Index [diap] 0.000805497012614
Known [qlco] 0.000801083707969
Dyslipidaemia [dsyn] 0.000795878479765
Assessment [hlca] 0.000793408469162
Various [irda] 0.000789115488353
GIVEN [cnce] 0.000787466983865
Searched [acty] 0.000785906756458
Select [acty] 0.000784740390983
Index [inpr] 0.000782480328228
Smoking [inbe] 0.000779763291285
Severe [qlco] 0.000779655303649
Physicians [prog] 0.000775935406943
Ratio [qnco] 0.000772846285106
C-reactive protein [aapp, imft] 0.000771133175328
Well [qlco] 0.000769331823994
Comorbidities [idcn] 0.00076745150797
Evaluation [ftcn] 0.000767359704191
Diseases [dsyn] 0.000756066138721
Required [ftcn] 0.000755045768081
Died [orgf] 0.000753825130485
Score [qnco] 0.000749991620363
Imaging [diap] 0.000749591744862
Doses [qnco] 0.000749062114152
Adults [aggp] 0.0007488102076
With [qlco] 0.000747493636384
Information [idcn] 0.000746997250447
experience [menp] 0.000745888723103
Defined [cnce] 0.000741524741656
Increasing [ftcn] 0.000741199085996
Aged [orga] 0.000738890848732
Cost Effectiveness [qnco] 0.00073856467453
Oral [spco] 0.00073680028134
Likely [qlco] 0.000733733186298
Androgen Deprivation Therapy [topp] 0.000731606130188
Treatments [topp] 0.000731061570829
Relationship [qlco] 0.000729709298752
Menopause [phsf] 0.00072605992303
Response [orga] 0.000725861540059
Meta-Analysis [inpr] 0.00072036932522
Average [qnco] 0.000718894939671
Mechanisms [ftcn] 0.000714727286626
national [inpr] 0.000712859082783
mmHg [qnco] 0.000712517167671
society [orgt] 0.000712471699403
investigated [ftcn] 0.000710568843761
Sex [orgf] 0.000707790709419
Previous [tmco] 0.000706531071672
Irradiation [npop] 0.000699403421236
strategies [menp] 0.000698801978122
Damage [inpo] 0.00069566525594
Exercise [dora] 0.000691050414524
acute [tmco] 0.000690288352949
Life Style [socb] 0.000683737285243
Small [qnco] 0.000682517420354
Presented [idcn] 0.000680867285146
In [qnco] 0.000677474984263
Vascular Malformations [anab] 0.000676272511182
cardiovascular risk factor [dsyn] 0.000675621446128
mg% [qnco] 0.000673478152543
Hormone Therapy [topp] 0.000670665775913
Bleeding [patf] 0.000668890889204
Single [popg] 0.000667032820233
Reducing [qlco] 0.000663803041297
investigate [ftcn] 0.000663414121142
days [tmco] 0.00066299380122
Calculated [ftcn] 0.000660708304622
Estimated [qnco] 0.000658498583705
Report [inpr] 0.000656508827415
reviewed [inpr] 0.000656230635753
patient care [hlca] 0.000656077759601
Agent [chvf] 0.000653562503457
adverse events [fndg] 0.000653423940885
Needed [qlco] 0.000652539830358
Program [cnce] 0.000652211644246
lowering [spco] 0.000651867720968
deaths [orgf] 0.000650832910056
Morbidity [qnco] 0.000650783564022
Total Cholesterol [lbpr] 0.000647472660668
Local [spco] 0.00064734681746
Heart disease [dsyn] 0.000646943441602
Knowledge [inpr] 0.000646904409521
Last [qlco] 0.000634508105847
Recommended [idcn] 0.000634198939014
Regression [patf] 0.000630423329884
Medication [phsu] 0.000627865173074
Six [qnco] 0.000627168082915
Appropriate [qlco] 0.000627071524467
Limited [ftcn] 0.000625666057341
System [ftcn] 0.000623932419521
Novel [tmco] 0.000621297987167
Cardiovascular Diseases [dsyn] 0.000616011396868
Young [tmco] 0.000613213046171
Functional [ftcn] 0.000612781751937
Central [spco] 0.000608339226864
Endothelial [tisu] 0.000603917574524
Cost [qnco] 0.000602579767737
Burden [idcn] 0.000602295572409
Secondary Prevention [topp] 0.000600182667349
Comparison [acty] 0.000599529906538
mg dl [qnco] 0.00059824654165
Surgical [hlca] 0.000597098105571
Long [qlco] 0.000595290008637
function [phsf] 0.000595048803597
Occurred [acty] 0.000593550163108
Status [qlco] 0.00059329033649
Addition [ftcn] 0.000592983300487
Prostate Cancer [neop] 0.000591514581244
Gender [orga] 0.000587326620369
statistically significant [qnco] 0.000586734004926
Center [spco] 0.000585512533105
strategy [menp] 0.000584452457646
Countries [geoa] 0.000584048635361
Hospitalization [hlca] 0.000584002195665
Approaches [spco] 0.000582143168208
Users [humn] 0.000581578361682
Conventional [qlco] 0.000580156698147
Plasma [bdsu] 0.000577207003897
Part [spco] 0.000572998855501
H+ [elii] 0.00056938152372
Measures [qnco] 0.000559877964599
Medications [phsu] 0.000559263357137
Risks [qlco] 0.000557246435739
Prescription [hlca] 0.000556454350181
Benefits [qnco] 0.000551894406909
Eight [qnco] 0.000551481130732
Control Group [grup] 0.000550760053972
Concern [idcn] 0.000545119313208
PLAN [dsyn] 0.00054380434452
Understanding [menp] 0.000543070619896
Female [fndg] 0.000542755008872
progression [patf] 0.000542336269397
Myocardial [spco] 0.000541443043799
Moderate [qlco] 0.000540547259008
Stage [tmco] 0.000538199933325
Affect [menp] 0.000537192228978
Inflammation [patf] 0.000537170714406
Obtained [ftcn] 0.000537065241454
Congenital heart disease [cgab, dsyn] 0.000535212267632
Confidence Intervals [qnco] 0.000534957377796
Adult [aggp] 0.000533804790451
secondary [neop] 0.000532675644214
Renal [bpoc] 0.000530855998493
Community [geoa] 0.000530336192636
divided [ftcn] 0.000530236231367
Flow [npop] 0.000530185689666
Marker [clna] 0.000529860473824
Interaction [ftcn] 0.000529663671659
Inflammatory [ftcn] 0.000529085595699
Late [tmco] 0.000528626330978
Class [inpr] 0.000528624292058
techniques [inpr] 0.000526886719832
Area [geoa] 0.000526383287955
Depression [mobd] 0.000526182523053
Database [inpr] 0.000525378893385
Normal [qlco] 0.000523338177151
Antioxidant [phsu] 0.00051912254919
Take [hlca] 0.000517534616186
Focus [spco] 0.000513176730818
methodology [inpr] 0.000512484211806
Low Density Lipoprotein Cholesterol [bacs, strd] 0.000511802410546
Relative [famg] 0.000511117139749
Cholesterol, LDL [bacs, strd] 0.000511068234862
Associations [menp] 0.00051050427593
Exist [cnce] 0.000510092555522
Cardiology [bmod] 0.000509449942942
Hospital [hcro, mnob] 0.0005073530587
Test [lbpr] 0.000505329831866
free [ftcn] 0.000505318937203
computed tomography [diap] 0.000505305330654
Diagnostic [fndg] 0.000503222112002
Good [qlco] 0.000502960347059
Sample [sbst] 0.000502771997335
Alternative [cnce] 0.000502150605187
Contribute [acty] 0.000496732287665
Insulin Resistance [patf] 0.000495848134801
Represent [acty] 0.000493547886539
Review, Systematic [inpr] 0.000492510973292
Correlation [qlco] 0.000492238637061
Monitoring [hlca] 0.000491636829827
prognostic [inpr] 0.000491298430205
lack [qlco] 0.000490611159312
Haemodialysis [topp] 0.000490564583203
Therapies [topp] 0.000490301719683
Metabolic [ftcn] 0.000489282716002
Proportion [qnco] 0.000489176361821
Active [ftcn] 0.000487927232817
Generation [tmco] 0.000487683181057
Triglycerides [bacs, lipd] 0.000487264381432
Breast [bpoc] 0.000487015395178
lesions [fndg] 0.00048672396191
Lung Cancer [neop] 0.000486129801955
Reference [idcn] 0.000485218672315
side effects [ftcn] 0.000485106913509
Cholesterol [bacs, strd] 0.000484408963128
Ischaemic [ftcn] 0.000482817516038
Dependent [qlco] 0.000481549229026
Out [spco] 0.000481185438487
Standard [qlco] 0.000480740497745
Few [qnco] 0.000480640574034
Low dose [qnco] 0.000477555191924
Extracted [topp] 0.000476579165924
Discharge [bdsu] 0.000475676490339
Recently [tmco] 0.000473758125915
size [spco] 0.000473542779827
choice [inbe] 0.000473409269318
Prostate [bpoc] 0.000473199945627
Same [qlco] 0.000472708982059
Of [spco] 0.000470923741858
Administration [ocac] 0.000470754793552
End [spco] 0.000470751174102
Females [fndg] 0.000469421677418
surveillance [ftcn] 0.000467902022155
Link [inpr] 0.000466492519022
Venous Thromboembolism [patf] 0.000464960065803
activity [dora] 0.00046443845551
Decade [qnco] 0.000463664319635
High dose [qnco] 0.000463083144627
topic3
treatment [ftcn] 0.0100774596701
P NOS [aapp, imft] 0.00820255605593
Study [mnob] 0.0069430099283
Group [idcn] 0.00675888692879
Women [popg] 0.00512070967035
Cardiovascular disease [dsyn] 0.00495842771976
Increased [qnco] 0.00456119491874
Methods [inpr] 0.00405484492101
CARDIOVASCULAR [bdsy] 0.00361633854262
Trial [resa] 0.00355829200772
Based [ftcn] 0.00336037396836
Compared [acty] 0.00329121987919
Mortality [qnco] 0.0032591907262
effects [qlco] 0.00322030543543
Age [orga] 0.00296616834434
Conclusions [idcn] 0.00292172662785
Men [popg] 0.00289645163756
Hypertension [dsyn] 0.00283486983998
Health [idcn] 0.0026552372436
Diabetes [dsyn] 0.00262893529748
Including [ftcn] 0.00240808120041
participants [popg] 0.00239249973527
included [ftcn] 0.00235006909564
N NOS [aapp, imft] 0.00232603519791
risk factors [qnco] 0.00230616376946
Stroke [dsyn] 0.00230425139845
radiotherapy [inpr] 0.00224479608249
Survival [acty] 0.00198669245277
therapy [ftcn] 0.0019520422178
Heart [bpoc] 0.00193690032557
Cases [ftcn] 0.00192871684028
Association [menp] 0.00192780483714
Prevention [topp] 0.00189127409589
Hormone replacement therapy [topp] 0.00188666136853
IMPACT [gngm] 0.00187765531077
Blood Pressure [orgf] 0.0018391630594
Subject [grup] 0.0018340118972
treated [topp] 0.00182373074133
Reduced [qlco] 0.0017891224957
Quality [qlco] 0.00178112274586
Atrial Fibrillation [patf] 0.00177472993031
Identified [qlco] 0.00173946364967
Range [qnco] 0.00171013147124
Dose [qnco] 0.00170748557397
Objective [inpr] 0.00170637821719
Management [ocac] 0.00169037609718
Care [acty] 0.00168789822991
Drug [phsu] 0.00167555590958
reduction [npop] 0.00167343244721
coronary heart disease [dsyn] 0.00166532135049
Efficacy [qlco] 0.00165442008888
Suggest [idcn] 0.00165337716113
Myocardial Infarction [dsyn] 0.00164169726247
months [tmco] 0.001638537476
Specific [qlco] 0.0016289829685
Evaluate [ftcn] 0.00161172247063
Levels [qlco] 0.00160063058556
Present [qnco] 0.00159571653215
Cardiac [bpoc] 0.0015953203448
Available [ftcn] 0.0015582719388
Observed [ftcn] 0.00155404839783
Hazard Ratio [qnco] 0.00154636144367
Performed [ftcn] 0.00153813456823
Reserve [acty] 0.00150004693995
Prognostic Factor [clna] 0.00148079541792
effective [qlco] 0.00145717254629
Adjusted [ftcn] 0.00143857026368
coronary artery disease [dsyn] 0.00142259891647
Evaluated [ftcn] 0.00141899136173
Old [tmco] 0.0013912444171
Complications [patf] 0.00137280233328
Benefit [qnco] 0.00136783778896
Therapeutic [topp] 0.00135438991303
High Risk [qlco] 0.00133383343278
Improved [qlco] 0.00132830952969
Purpose [ftcn] 0.00132419019595
placebo [topp] 0.00129035918131
Guidelines [inpr] 0.00127638811716
Statins [orch, phsu] 0.00127155358934
Combination [qlco] 0.00126071971858
Reported [inpr] 0.00124824587246
baseline [bodm] 0.00123468129728
Assessed [acty] 0.00123383761959
Approach [spco] 0.00121505160694
Main [qlco] 0.00120996521277
Induced [ftcn] 0.00120318556958
Improvement [cnce] 0.00120199301554
Breast Cancer [neop] 0.00119637835633
Children [aggp] 0.00119138960661
Current [tmco] 0.00118162519193
Decrease [qlco] 0.00117945931589
Life [idcn] 0.00117820907531
Statin [orch, phsu] 0.00117565771574
Heart failure [dsyn] 0.00117250493036
Medical [ftcn] 0.00116929823601
Odds Ratio [qnco] 0.00116567843627
interventions [hlca] 0.00116053003915
condition [dsyn] 0.00115466268005
Surgery [bmod] 0.0011532313229
People [popg] 0.00114715426003
intervention [hlca] 0.00114366039696
Drug Therapy [topp] 0.001143155565
Design [acty] 0.00113450189376
Independent [idcn] 0.00113173637183
Score [qnco] 0.00111065142237
Aspirin [orch, phsu] 0.00110870930474
Large [qnco] 0.00110153560822
symptoms [ftcn] 0.00109697787294
experience [menp] 0.00109374460972
Received [qlco] 0.0010797562943
Published [ocac] 0.00107277646365
Evaluation [ftcn] 0.00106902354681
Five [qnco] 0.00106881233661
Lipid [lipd] 0.00106711556685
Well [qlco] 0.00105612336114
History [ocdi] 0.00105527526807
hypertensive [fndg] 0.00104759429096
Following [tmco] 0.00104227296522
Morbidity [qnco] 0.00103165580883
ischaemic heart disease [dsyn] 0.00103061143816
search [inpr] 0.00102869561515
chronic [tmco] 0.00102680983487
Decreased [qnco] 0.00101453325034
Conduct [inbe] 0.00100336216757
Receive [qlco] 0.00100288077747
PREVENT [phsu] 0.000999634428805
cardiovascular events [fndg] 0.000999524731599
postmenopausal [tmco] 0.000999300759903
findings [ftcn] 0.00099062968769
Adherence [ftcn] 0.000987320474351
Metabolic syndrome [dsyn] 0.000981817518967
Several [qnco] 0.000980234482707
C-reactive protein [aapp, imft] 0.000974470162415
Primary [qlco] 0.000967231408771
Information [idcn] 0.000965945622297
Issue [fndg] 0.000962448826469
objectives [inpr] 0.00095658676611
coronary [bpoc] 0.000953290472191
Support [medd] 0.000951429929537
Chronic kidney disease [dsyn] 0.000950729054047
Target [ftcn] 0.000950717556022
randomized [resa] 0.000947168979129
Recommended [idcn] 0.000943967401837
Venous malformation [anab] 0.00094389069494
Addition [ftcn] 0.000933082382611
Physical activity [dora] 0.000932998586657
Radiation [npop] 0.000931290241537
Survivors [podg] 0.000930739555866
Acute myocardial infarction [dsyn] 0.00092672016719
Safety [hcpp] 0.000925344642793
Assessment [hlca] 0.00091862440572
Oral [spco] 0.000917279043267
Treatments [topp] 0.000915029879805
Combined [qlco] 0.000914560618988
GIVEN [cnce] 0.000902948694114
weeks [tmco] 0.000902607783114
practice [menp] 0.000894695804107
In [qnco] 0.000890888772364
Literature [inpr] 0.000889411398978
Known [qlco] 0.000888729525918
Elderly [popg] 0.000887401787861
Mechanisms [ftcn] 0.000883673350431
Often [tmco] 0.000883288226795
Sclerotherapy [topp] 0.00087539721684
Physicians [prog] 0.000874500019723
Adults [aggp] 0.00087381503679
Measured [qlco] 0.000872901741778
Need [qlco] 0.000872360216294
Irradiation [npop] 0.000870141485245
Effectiveness [qlco] 0.000868769995903
Androgen Deprivation Therapy [topp] 0.000868639120929
Characteristics [qlco] 0.000864035447615
Ratio [qnco] 0.000862918565554
Prostate Cancer [neop] 0.000856163603056
Severe [qlco] 0.000852645256961
Additional [ftcn] 0.000851872617153
Medication [phsu] 0.000845661675583
Cost Effectiveness [qnco] 0.000844691766739
Estrogen [horm, phsu, strd] 0.00084374698686
days [tmco] 0.000838116086871
Diagnosed [fndg] 0.00083384753732
Body Mass Index [diap] 0.000833224954437
Multiple [qnco] 0.000826402095564
Heart disease [dsyn] 0.000819556965886
Established [qlco] 0.000818663754727
Complex [qlco] 0.000817085076256
Cardiovascular Diseases [dsyn] 0.000815107622344
vascular [bpoc] 0.000814101375467
Atherosclerosis [dsyn] 0.00081358919643
Last [qlco] 0.000813005510942
GY [geoa] 0.000813003281575
Agent [chvf] 0.000810882205247
???lead [elii, hops] 0.000808041821451
Estimated [qnco] 0.000806616707881
Marker [clna] 0.000806263131235
Plasma [bdsu] 0.000804781736065
Status [qlco] 0.000799458515558
acute [tmco] 0.000798476121915
Controlled [ftcn] 0.00079655554126
function [phsf] 0.000793587365653
APPEAR [qlco] 0.000793115478415
Drugs [phsu] 0.000793020419454
Beta-Blockers [phsu] 0.000792098348434
strategies [menp] 0.000787295570278
Increasing [ftcn] 0.000785364024556
Events [evnt] 0.000775476263473
considered [idcn] 0.000775456989717
Values [qlco] 0.000773028853183
setting [ftcn] 0.000772739349374
Response [orga] 0.000770547025702
Imaging [diap] 0.000760291413129
Index [inpr] 0.000759305024482
Obesity [dsyn] 0.000757023913899
Average [qnco] 0.000756481071955
Diet [food] 0.000751950279375
Comorbidities [idcn] 0.000747804581519
Damage [inpo] 0.000745709694399
Therapies [topp] 0.000743965868807
Part [spco] 0.000743200704938
Searched [acty] 0.000742802887478
Aged [orga] 0.000740470291192
national [inpr] 0.000733651498055
Confidence Intervals [qnco] 0.000730932208999
Knowledge [inpr] 0.000730675214578
Standard [qlco] 0.000727522859231
Life Style [socb] 0.000724163151556
Select [acty] 0.000721120204433
Limited [ftcn] 0.000717934431192
Future [tmco] 0.000713042499438
Dyslipidaemia [dsyn] 0.000711409944071
lowering [spco] 0.000707982858658
Needed [qlco] 0.000705091837772
Previous [tmco] 0.000700637623839
mg dl [qnco] 0.000699592572217
Parameters [fndg] 0.000698978604594
lesions [fndg] 0.000690717350436
Concern [idcn] 0.000690295531723
Young [tmco] 0.000687901812943
Profile [lbpr] 0.000685871390951
Elevated [qlco] 0.00068433700117
Update [tmco] 0.000682763111766
Late [tmco] 0.00068054824252
adverse events [fndg] 0.000678545069469
Functional [ftcn] 0.000676311372519
Users [humn] 0.00067486943284
Article [inpr] 0.000674578864845
Medications [phsu] 0.000672081102166
Make [ftcn] 0.000671861539526
Diabetes Mellitus [dsyn] 0.000670154341755
Report [inpr] 0.000668626488139
Vascular Malformations [anab] 0.000664487502794
Authors [prog] 0.000662508139506
Regression [patf] 0.000662488766561
Risks [qlco] 0.000662357575551
Benefits [qnco] 0.00066056604058
Hospital [hcro, mnob] 0.000660065625631
Various [irda] 0.00065983014179
Address [inpr] 0.000659704355567
Examined [fndg] 0.000658713006251
Central [spco] 0.000657510858075
Defined [cnce] 0.000654675168998
deaths [orgf] 0.000650024379252
Acute Coronary Syndrome [dsyn] 0.000631782479626
Relationship [qlco] 0.000629057649996
Hormone Therapy [topp] 0.000628810113377
Required [ftcn] 0.000623888145576
Sex [orgf] 0.000620595417325
Optimal [qlco] 0.000620268128428
Surgical [hlca] 0.00061863847578
Represent [acty] 0.000616304611688
Recently [tmco] 0.000615149465119
Reducing [qlco] 0.000613243736566
prognostic [inpr] 0.000610272490191
Long [qlco] 0.000610058096985
Relative [famg] 0.000609660509137
secondary [neop] 0.000609293995605
Decade [qnco] 0.000607306548514
Comparison [acty] 0.000604678006347
paediatric [bmod] 0.000599034937638
Female [fndg] 0.000592978876003
Appropriate [qlco] 0.000586120216553
M NOS [aapp, imft] 0.000585911500895
Alone [qnco] 0.000581873258467
With [qlco] 0.000579201564994
System [ftcn] 0.000578614786699
Small [qnco] 0.00057656668476
Novel [tmco] 0.000574693160809
mg% [qnco] 0.000572606072662
Of [spco] 0.000570875644323
statistically significant [qnco] 0.000569785449527
Ischaemic [ftcn] 0.000565025126835
Approaches [spco] 0.000564976265389
measurements [ftcn] 0.000561495620985
Cost [qnco] 0.000560212953928
admission [hlca] 0.000558763941917
Likely [qlco] 0.000558672071944
Help [socb] 0.000557322462297
Moderate [qlco] 0.000556946827743
Chemotherapy [topp] 0.000554161365048
Prescription [hlca] 0.000553295192964
LTD [ortf] 0.000552163338372
Single [popg] 0.000552014629453
Take [hlca] 0.000551913825555
Inflammation [patf] 0.00055000275496
reviewed [inpr] 0.000548313139997
Process [bpoc] 0.000541637171392
Introduction [hlca] 0.000541470232382
Occurred [acty] 0.000541039297823
investigated [ftcn] 0.000540884356522
rats [mamm] 0.000540809818164
Countries [geoa] 0.000539832371684
Metabolic [ftcn] 0.000537822806276
recommendations [idcn] 0.000536417225742
Six [qnco] 0.000535426089688
Currently [tmco] 0.000532833137665
Relevant [qlco] 0.000532773217506
Presented [idcn] 0.000531267122629
Normal [qlco] 0.000530445536257
mmHg [qnco] 0.000530112662585
Endothelial [tisu] 0.000529368854726
Meta-Analysis [inpr] 0.0005269071992
Consecutive [qlco] 0.000526906492247
cardiovascular risk factor [dsyn] 0.000526789284166
Play [dora] 0.000526260461714
Risk Ratios [qnco] 0.000526154606783
Primary Prevention [topp] 0.000525765021481
Program [cnce] 0.000522982999097
investigate [ftcn] 0.000522900730417
Duration [tmco] 0.00052224446599
Ischaemic stroke [dsyn] 0.000521250466593
side effects [ftcn] 0.000520282529129
High dose [qnco] 0.000515747545594
Burden [idcn] 0.000513887662115
Relative Risk [qnco] 0.000513263533712
Onset [qlco] 0.00051214016639
Now [tmco] 0.000510979969051
lack [qlco] 0.00050939359229
Alternative [cnce] 0.000508585646962
Direct [qlco] 0.000506534312874
Oxidative Stress [comd] 0.000506337402171
Adult [aggp] 0.000505998947348
Dialysis [npop] 0.000505416846471
Measures [qnco] 0.000505256953814
Exercise [dora] 0.000505213069426
patient care [hlca] 0.000504831467871
Biomarkers [clna] 0.00050467572971
activity [dora] 0.000502941632167
majority [socb] 0.0005020234797
High Density Lipoprotein Cholesterol [bacs, lipd] 0.000500020055103
Obtained [ftcn] 0.000498887546981
Diagnostic [fndg] 0.000498044064427
Cholesterol [bacs, strd] 0.000496437308502
Diseases [dsyn] 0.000496407089274
Exposure NOS [inpo] 0.000494997990914
Initial [tmco] 0.000494636572349
Bleeding [patf] 0.00049428085229
Link [inpr] 0.000493488925064
Proportion [qnco] 0.000490287503706
Application [hlca] 0.000489716573985
Post [tmco] 0.000488582797443
Stable [qlco] 0.000488276822927
Improving [qlco] 0.000485492795911
strategy [menp] 0.000484986188697
Cardiology [bmod] 0.000483490704144
Percutaneous [spco] 0.000481306591948
Extracted [topp] 0.000481297853321
Guide [prog] 0.000480204898242
surveillance [ftcn] 0.000479205920624
Active [ftcn] 0.000478819733628
Gender [orga] 0.000478300313485
Understanding [menp] 0.000478285295617
size [spco] 0.000477764049331
Menopause [phsf] 0.000477718883243
Associations [menp] 0.000476750226173
Secondary Prevention [topp] 0.000474511833657
Complete [qlco] 0.000472754488741
criteria [inpr] 0.000470707813672
Seven [qnco] 0.000469411332554
Symptomatic [ftcn] 0.000468530433602
Center [spco] 0.000468105129888
Advance [medd] 0.00046635081628
Contribute [acty] 0.000461724752197
Ageing [orgf] 0.000460493526849
Critical [qlco] 0.000460043371545
Flow [npop] 0.000459256862357
Affect [menp] 0.000459083861691
Derived [qlco] 0.000454089950948
prospective [resa] 0.000453893115663
Access [spco] 0.000452241819604
Technique [ftcn] 0.000452193231871
General Population [popg] 0.000451687317198
Haemodialysis [topp] 0.000451180503772
Administration [ocac] 0.000450206524929
Costs [qnco] 0.000448040977509
properties [qlco] 0.000448039752002
free [ftcn] 0.000447149025015
Seen [qlco] 0.0004467265943
Provided [acty] 0.000446094840442
Systolic blood pressure [clna] 0.00044509364908
Home [cnce] 0.000445084681863
topic4
P NOS [aapp, imft] 0.00958063633249
treatment [ftcn] 0.00885528119988
Cardiovascular disease [dsyn] 0.00706911766839
Study [mnob] 0.00673859259162
Trial [resa] 0.00649331074588
Group [idcn] 0.00631410366311
Mortality [qnco] 0.00523848150375
Women [popg] 0.00512303357861
Methods [inpr] 0.00493812896095
Age [orga] 0.00421266267495
Compared [acty] 0.00372905384396
Diabetes [dsyn] 0.00363564712705
Increased [qnco] 0.0034946268107
effects [qlco] 0.0034841967719
radiotherapy [inpr] 0.00330375765435
Based [ftcn] 0.00314741549349
included [ftcn] 0.00305604728358
N NOS [aapp, imft] 0.00293581196325
months [tmco] 0.00279447295978
Health [idcn] 0.00278314684512
therapy [ftcn] 0.00273702486102
Conclusions [idcn] 0.00268352710712
Heart [bpoc] 0.00262239294571
Hypertension [dsyn] 0.00254171676239
CARDIOVASCULAR [bdsy] 0.00249153402382
Induced [ftcn] 0.00224289428304
Cardiac [bpoc] 0.00221694175735
Care [acty] 0.00217978758225
participants [popg] 0.00217712438835
treated [topp] 0.00207120487676
Men [popg] 0.0020647569528
Blood Pressure [orgf] 0.00193979015921
Suggest [idcn] 0.00191985743522
Dose [qnco] 0.00177973687613
Observed [ftcn] 0.00176465444736
risk factors [qnco] 0.00175848482304
Complications [patf] 0.00171006257356
Hormone replacement therapy [topp] 0.00170783658341
Association [menp] 0.00170613436455
Reserve [acty] 0.00168056319508
Including [ftcn] 0.00166258283042
Prevention [topp] 0.00166090337866
Levels [qlco] 0.00165372494123
High Risk [qlco] 0.00160228121396
Stroke [dsyn] 0.00156751421244
Efficacy [qlco] 0.00156650209919
Management [ocac] 0.00153504292162
Performed [ftcn] 0.00153455450563
Primary [qlco] 0.00152802682239
Present [qnco] 0.00151553458076
Identified [qlco] 0.00151481546103
Range [qnco] 0.00150180285417
Therapeutic [topp] 0.00148708497132
Benefit [qnco] 0.00147757608957
coronary heart disease [dsyn] 0.00146570298639
Statins [orch, phsu] 0.00146549000982
Specific [qlco] 0.00145345947955
Drug [phsu] 0.0014382195835
Atrial Fibrillation [patf] 0.00143569526913
Quality [qlco] 0.00141884830564
Objective [inpr] 0.00140307700929
Reduced [qlco] 0.00138821715677
Survival [acty] 0.0013837200176
People [popg] 0.00136831783634
Cases [ftcn] 0.00136763711043
Available [ftcn] 0.00136554558502
Sclerotherapy [topp] 0.00134439694957
Current [tmco] 0.00133510384193
effective [qlco] 0.00133351566225
Old [tmco] 0.00132306593336
placebo [topp] 0.00131521116604
Prognostic Factor [clna] 0.00129823390438
Reported [inpr] 0.0012932876865
Receive [qlco] 0.00129073692332
Heart failure [dsyn] 0.00128386507379
reduction [npop] 0.00127879280667
IMPACT [gngm] 0.00127666335917
Conduct [inbe] 0.00127376881949
Improved [qlco] 0.00127047144705
Main [qlco] 0.00126425988199
Parameters [fndg] 0.00122685812066
Children [aggp] 0.0012181037281
Decreased [qnco] 0.00121658028059
Evaluate [ftcn] 0.00121268487576
Adherence [ftcn] 0.00120719299135
randomized [resa] 0.00120593317367
GY [geoa] 0.00120192990389
baseline [bodm] 0.0012018852416
History [ocdi] 0.00119945611741
Guidelines [inpr] 0.00119871775702
Aspirin [orch, phsu] 0.00119517452222
Subject [grup] 0.00119353654449
Myocardial Infarction [dsyn] 0.0011769873019
Hazard Ratio [qnco] 0.00117218997664
coronary artery disease [dsyn] 0.00116510021732
Published [ocac] 0.00116497030902
Drug Therapy [topp] 0.00115673900072
Update [tmco] 0.00115174883531
coronary [bpoc] 0.00115091724728
interventions [hlca] 0.00115027084394
vascular [bpoc] 0.00114511047433
Irradiation [npop] 0.00114466995219
intervention [hlca] 0.00113676137441
postmenopausal [tmco] 0.00112967476525
Surgery [bmod] 0.0011265025386
PREVENT [phsu] 0.00111853737597
Severe [qlco] 0.00110301134581
Several [qnco] 0.00109896965195
Evaluated [ftcn] 0.00109087241799
Approach [spco] 0.00108948001288
Breast Cancer [neop] 0.00108821542255
Lipid [lipd] 0.00107916356612
Elderly [popg] 0.00107055242084
condition [dsyn] 0.00106562125604
Chronic kidney disease [dsyn] 0.00106087144362
Received [qlco] 0.00105337380819
Life [idcn] 0.00105155423237
Improvement [cnce] 0.00104206293469
Design [acty] 0.00103655189906
Ratio [qnco] 0.0010347833183
Acute myocardial infarction [dsyn] 0.00101790397781
Effectiveness [qlco] 0.00101606780713
Atherosclerosis [dsyn] 0.00100983765084
Purpose [ftcn] 0.0010060734873
Average [qnco] 0.000999621888862
Prostate Cancer [neop] 0.000991841665551
practice [menp] 0.000990189995332
Treatments [topp] 0.000986958618217
Article [inpr] 0.000986608934694
Authors [prog] 0.000985793270887
strategies [menp] 0.000980560365301
Combined [qlco] 0.000979471574769
setting [ftcn] 0.000976976933866
Statin [orch, phsu] 0.000966060192779
weeks [tmco] 0.00096408572923
Adjusted [ftcn] 0.00096225338875
Often [tmco] 0.000955603187204
Medical [ftcn] 0.000939880705701
Assessed [acty] 0.00093929531438
C-reactive protein [aapp, imft] 0.000933000290639
Body Mass Index [diap] 0.000932931239626
Androgen Deprivation Therapy [topp] 0.000921604148127
Controlled [ftcn] 0.000918822492095
search [inpr] 0.000917770344518
Additional [ftcn] 0.00091649061527
deaths [orgf] 0.000913865114487
Likely [qlco] 0.00091236920199
Diagnosed [fndg] 0.000911610600422
Survivors [podg] 0.000910186470686
Values [qlco] 0.000908371636604
Reducing [qlco] 0.000904498016974
Decrease [qlco] 0.000903989556433
Radiation [npop] 0.000898564857379
Odds Ratio [qnco] 0.000891469862434
Evaluation [ftcn] 0.000887721119657
Profile [lbpr] 0.000884806640515
Metabolic syndrome [dsyn] 0.000881513189361
Need [qlco] 0.000877033256225
Female [fndg] 0.000872593118641
Benefits [qnco] 0.0008668046176
Searched [acty] 0.000861390840478
Agent [chvf] 0.000854930464358
Six [qnco] 0.000854267882909
Large [qnco] 0.000851536983422
acute [tmco] 0.000850290101181
Characteristics [qlco] 0.000847579336888
Examined [fndg] 0.000845231405254
Information [idcn] 0.000843700580154
Limited [ftcn] 0.000843302893749
Select [acty] 0.000831519047068
Venous malformation [anab] 0.00082853421006
Assessment [hlca] 0.000828281118586
function [phsf] 0.000828032206529
Oral [spco] 0.000819396018651
Estrogen [horm, phsu, strd] 0.000816360910443
Following [tmco] 0.000813164696628
findings [ftcn] 0.000812455975655
Functional [ftcn] 0.00080674159795
Support [medd] 0.000804011835055
Standard [qlco] 0.000803521208012
Confidence Intervals [qnco] 0.000801737823718
Issue [fndg] 0.000795885686631
ischaemic heart disease [dsyn] 0.000792479346911
Comorbidities [idcn] 0.000792342079656
objectives [inpr] 0.000788402167585
GIVEN [cnce] 0.000786271893556
Target [ftcn] 0.000785900267244
Estimated [qnco] 0.000781597151118
symptoms [ftcn] 0.000781280870756
days [tmco] 0.000777797505814
Menopause [phsf] 0.000777557880615
Score [qnco] 0.00077703968639
lesions [fndg] 0.00077333757468
Index [inpr] 0.000768942940475
Events [evnt] 0.000763460092832
Defined [cnce] 0.000762469749384
recommendations [idcn] 0.000753042335589
Morbidity [qnco] 0.000752545839843
Measured [qlco] 0.000752270000138
Appropriate [qlco] 0.000751821035425
Medication [phsu] 0.000749362092063
Currently [tmco] 0.000745457800079
Dyslipidaemia [dsyn] 0.000743152605769
Hospital [hcro, mnob] 0.000738940560179
Drugs [phsu] 0.000738773411438
statistically significant [qnco] 0.00073843979783
Report [inpr] 0.000733198598602
Safety [hcpp] 0.000727519704676
Status [qlco] 0.000726106302509
progression [patf] 0.000723937816851
Marker [clna] 0.000721006790128
Damage [inpo] 0.000720547341129
Imaging [diap] 0.000718012903707
cardiovascular risk factor [dsyn] 0.000713597132662
chronic [tmco] 0.000713190984898
Obtained [ftcn] 0.000709967891553
Multiple [qnco] 0.000708617034306
???lead [elii, hops] 0.000706303932524
Novel [tmco] 0.000696660516827
Post [tmco] 0.00069508121369
Five [qnco] 0.000694005307965
Previous [tmco] 0.000693888041461
Associations [menp] 0.000693812237099
Mechanisms [ftcn] 0.000690621218062
Future [tmco] 0.000689756593831
Well [qlco] 0.000687857311318
Addition [ftcn] 0.000687610659694
Physicians [prog] 0.000684022723165
Prescription [hlca] 0.000683395409575
Combination [qlco] 0.000683044125915
experience [menp] 0.000681966139805
Established [qlco] 0.000681812663098
Diseases [dsyn] 0.000681425857184
reviewed [inpr] 0.000679664135442
Last [qlco] 0.000676146263907
computed tomography [diap] 0.000672990554314
secondary [neop] 0.000671454254885
strategy [menp] 0.000669393211931
Increasing [ftcn] 0.000668107327128
Concern [idcn] 0.000667678323398
Known [qlco] 0.000666355654136
Response [orga] 0.000665454903542
Approaches [spco] 0.000664692262105
Guide [prog] 0.000663885830179
Total Cholesterol [lbpr] 0.000661798607953
Complex [qlco] 0.000656761558364
mg% [qnco] 0.00065629710297
considered [idcn] 0.000655879453067
Required [ftcn] 0.000655469921906
Long [qlco] 0.000653396209821
Program [cnce] 0.000653085997637
Smoking [inbe] 0.000651523675037
Obesity [dsyn] 0.000651222633378
Relevant [qlco] 0.000644759891177
Diabetes Mellitus [dsyn] 0.000644608342944
Cardiovascular Diseases [dsyn] 0.000642829867222
Take [hlca] 0.000642168889703
Heart disease [dsyn] 0.000641128709505
Needed [qlco] 0.000641091953492
Secondary Prevention [topp] 0.000638265625501
Moderate [qlco] 0.00063794989041
Various [irda] 0.000637399811978
Beta-Blockers [phsu] 0.00063677191909
Single [popg] 0.000635217521915
Aged [orga] 0.000632247496179
Young [tmco] 0.000629752972863
Recommended [idcn] 0.000629568926367
Alone [qnco] 0.000629328160288
Burden [idcn] 0.000626979846196
peripheral arterial disease [dsyn] 0.000624758421081
Cost [qnco] 0.000618893348409
cardiovascular events [fndg] 0.000617982319797
hypertensive [fndg] 0.000617478286917
Sex [orgf] 0.000615373678423
Relative [famg] 0.000611381507022
Bias [idcn] 0.000610029897889
Life Style [socb] 0.000609171292216
LTD [ortf] 0.000608502898797
Risks [qlco] 0.000607030992446
Relationship [qlco] 0.000606799947797
Address [inpr] 0.000606245030777
adverse events [fndg] 0.000606163507464
society [orgt] 0.000602884222271
Central [spco] 0.000600340577732
H+ [elii] 0.000598829595613
investigate [ftcn] 0.000598313958814
In [qnco] 0.000598307899341
Cost Effectiveness [qnco] 0.000597750877588
Affect [menp] 0.00059398395423
Local [spco] 0.00059389651665
Recently [tmco] 0.000589582572459
R- [spco] 0.000586911730102
Make [ftcn] 0.000581964508557
variables [qlco] 0.000577674308834
investigated [ftcn] 0.000575259533673
Medications [phsu] 0.000573234842246
Endothelial [tisu] 0.000573042900051
Of [spco] 0.000571542258331
Independent [idcn] 0.000571407260652
Ischaemic [ftcn] 0.000570344388817
Normal [qlco] 0.000569324561772
Critical [qlco] 0.000567014427545
Countries [geoa] 0.000563630828942
Meta-Analysis [inpr] 0.000560403296495
Surgical [hlca] 0.00055909236367
mmHg [qnco] 0.000554056554322
Part [spco] 0.000553968012479
national [inpr] 0.000552676151516
Occurred [acty] 0.000552017113397
Few [qnco] 0.000549958297547
Small [qnco] 0.000549231093752
Ischaemic stroke [dsyn] 0.000548266259438
Breast [bpoc] 0.000547471293544
M NOS [aapp, imft] 0.000545240355472
Literature [inpr] 0.00054402830359
Link [inpr] 0.000543852167114
Inflammation [patf] 0.00054360522802
Physical activity [dora] 0.000541726492493
Hospitalization [hlca] 0.000539781612184
With [qlco] 0.000539035179599
Collected [idcn] 0.000538783440011
Record [inpr] 0.00053788469367
Acute Coronary Syndrome [dsyn] 0.000536837770371
Proportion [qnco] 0.000533464318401
Sample [sbst] 0.000530892345614
System [ftcn] 0.000529186364323
APPEAR [qlco] 0.000528096974442
Clinical Trials [resa] 0.000527269910156
Measures [qnco] 0.000527006646398
Died [orgf] 0.000524390808786
Presented [idcn] 0.000523297232634
Therapies [topp] 0.000523260794401
Understanding [menp] 0.000522063661494
divided [ftcn] 0.000522039819102
Symptomatic [ftcn] 0.00052153485706
Active [ftcn] 0.00052068635078
Database [inpr] 0.000518377547356
Congenital heart disease [cgab, dsyn] 0.000517702035376
mg dl [qnco] 0.000517165279154
Primary Prevention [topp] 0.000516306089271
Depression [mobd] 0.000515256924246
Order [inpr] 0.000515222809507
Onset [qlco] 0.000514753613382
Regression [patf] 0.000514705457674
Elevated [qlco] 0.000513260872475
Adults [aggp] 0.000511247330989
Adult [aggp] 0.000510237991726
Vascular Malformations [anab] 0.000509336867708
prospective [resa] 0.00050907495292
Advance [medd] 0.000506163602241
Measure [qnco] 0.000506040509667
Region [geoa] 0.000505525104148
Discharge [bdsu] 0.000503810223516
Doses [qnco] 0.000500568943071
Contribute [acty] 0.000498852883269
Knowledge [inpr] 0.00049849225838
Altered [ftcn] 0.000498483985943
free [ftcn] 0.000497572235329
Colorectal Cancer [neop] 0.000495606676973
PLAN [dsyn] 0.00049521946739
patient care [hlca] 0.000495091273398
size [spco] 0.000495081343576
Class [inpr] 0.000494862545981
Help [socb] 0.000493951154491
Costs [qnco] 0.000491605489284
Center [spco] 0.000490874024779
Risk Ratios [qnco] 0.000490512043994
rats [mamm] 0.000489634749541
Improving [qlco] 0.000484037980179
Seen [qlco] 0.000483997199572
Plasma [bdsu] 0.00048327337084
Antioxidant [phsu] 0.000482653960543
Duration [tmco] 0.000479896119986
Gender [orga] 0.000479004637226
Primary Care [hlca] 0.000472559401372
Registry [inpr] 0.000472291301057
prescribing [hlca] 0.000470926240344
Relative Risk [qnco] 0.000470754514528
Late [tmco] 0.000469059507687
Activation [acty] 0.000468700269199
Ireland [geoa] 0.000468582423961
Consecutive [qlco] 0.000465660638964
Initiation [menp] 0.000464147128431
Focus [spco] 0.000464042102977
Users [humn] 0.000462352244411
Generation [tmco] 0.00046207887542
Advanced [qlco] 0.000461246003287
Variability [cnce] 0.000461095116572
Estimate [qnco] 0.000460769145089
lack [qlco] 0.000459605445386
Segment [spco] 0.000458002117888
Chemotherapy [topp] 0.000457295498547
Tool [mnob] 0.000455603203283
Eight [qnco] 0.000454877917044
Stage [tmco] 0.00045478215401
Play [dora] 0.000454109823262
Represent [acty] 0.000454053483209
Technique [ftcn] 0.000453462992445
Optimal [qlco] 0.000453393718099
Correlated [qlco] 0.000452357926721
topic5
treatment [ftcn] 0.00834013319662
Study [mnob] 0.00752915327215
P NOS [aapp, imft] 0.00749765379775
Compared [acty] 0.00546973085956
Increased [qnco] 0.0052955289842
Cardiovascular disease [dsyn] 0.004860374847
Women [popg] 0.00474355963105
Group [idcn] 0.00452330445866
Methods [inpr] 0.00412980099336
Trial [resa] 0.00393038026153
Mortality [qnco] 0.00379413580972
Age [orga] 0.0037168889988
Based [ftcn] 0.00350322865745
effects [qlco] 0.00344598903658
Hypertension [dsyn] 0.00302531436148
Conclusions [idcn] 0.00284702256685
radiotherapy [inpr] 0.00279823670107
CARDIOVASCULAR [bdsy] 0.00276324850892
Men [popg] 0.00266890537134
Stroke [dsyn] 0.00261684762287
Prevention [topp] 0.0025862860443
months [tmco] 0.00250797453817
N NOS [aapp, imft] 0.00245587140754
Including [ftcn] 0.00243106053303
treated [topp] 0.00242801376215
included [ftcn] 0.00231816617744
Levels [qlco] 0.00226733554331
therapy [ftcn] 0.00213510031821
risk factors [qnco] 0.00210445222144
participants [popg] 0.00207386484129
Diabetes [dsyn] 0.00203480763405
Survival [acty] 0.00202693771573
Specific [qlco] 0.00201382400173
Present [qnco] 0.00200871264588
Health [idcn] 0.00197535461944
Management [ocac] 0.00196173389913
Association [menp] 0.00193832743672
Efficacy [qlco] 0.00190006139453
High Risk [qlco] 0.00181745362692
Suggest [idcn] 0.00180242555999
Statins [orch, phsu] 0.00179647143472
Cardiac [bpoc] 0.00178358029698
Evaluated [ftcn] 0.00175668040968
Observed [ftcn] 0.00173647660759
Hormone replacement therapy [topp] 0.00167550068314
Cases [ftcn] 0.00166780057393
Induced [ftcn] 0.0016666073585
Quality [qlco] 0.00166468598404
baseline [bodm] 0.00162369570018
Receive [qlco] 0.00162154888382
Myocardial Infarction [dsyn] 0.00159943284072
Heart [bpoc] 0.00157412575499
People [popg] 0.00152628217247
Reserve [acty] 0.00152335612767
reduction [npop] 0.00152024439382
IMPACT [gngm] 0.00150061730584
coronary heart disease [dsyn] 0.0014938944445
Dose [qnco] 0.00145771148691
Evaluate [ftcn] 0.00145363802565
placebo [topp] 0.00145155394851
Assessed [acty] 0.00145057526201
Objective [inpr] 0.00140050992355
coronary artery disease [dsyn] 0.00138520409705
Old [tmco] 0.00138336696836
Authors [prog] 0.00137698179394
Performed [ftcn] 0.00137599172452
Blood Pressure [orgf] 0.00137432365091
postmenopausal [tmco] 0.00135069267267
Hazard Ratio [qnco] 0.00134992689529
Reduced [qlco] 0.0013257668869
considered [idcn] 0.00132482484504
Current [tmco] 0.001318489365
Benefit [qnco] 0.00130712201989
Subject [grup] 0.0013009808385
Surgery [bmod] 0.00129824379477
Received [qlco] 0.00127535189378
Metabolic syndrome [dsyn] 0.00125277829198
Safety [hcpp] 0.00124676505156
Lipid [lipd] 0.00124376721673
Published [ocac] 0.00123977634268
Range [qnco] 0.00123509330115
Complications [patf] 0.00123482443042
Heart failure [dsyn] 0.00123408579225
Primary [qlco] 0.00122687841833
coronary [bpoc] 0.00122638593465
Life [idcn] 0.00120513950645
ischaemic heart disease [dsyn] 0.00120463628466
Need [qlco] 0.00120433411097
Survivors [podg] 0.00119775431666
Drug Therapy [topp] 0.00119659173505
GY [geoa] 0.00118912292016
Prognostic Factor [clna] 0.001170120943
Aged [orga] 0.00116499597168
Available [ftcn] 0.00116039993267
condition [dsyn] 0.00114608805657
Reported [inpr] 0.00114560634534
interventions [hlca] 0.00114181485465
Information [idcn] 0.00113929964964
PREVENT [phsu] 0.00113612537932
Odds Ratio [qnco] 0.00113053575691
Approach [spco] 0.00112453427365
Drugs [phsu] 0.00111224766016
Statin [orch, phsu] 0.00111175897556
Improved [qlco] 0.00109742694232
Severe [qlco] 0.00109170799774
objectives [inpr] 0.00108772523667
Design [acty] 0.00108771055644
Aspirin [orch, phsu] 0.00108749495859
Assessment [hlca] 0.00108124155807
Therapeutic [topp] 0.00106594429082
randomized [resa] 0.00106352455053
Improvement [cnce] 0.00106146869763
Adherence [ftcn] 0.00105636307302
Care [acty] 0.00105444986776
In [qnco] 0.00105091243589
Combination [qlco] 0.00104087286038
Article [inpr] 0.00104048148248
Estrogen [horm, phsu, strd] 0.00103971268893
intervention [hlca] 0.00103221981137
Decrease [qlco] 0.00103032003103
Parameters [fndg] 0.00102700589761
Conduct [inbe] 0.00102376086584
Purpose [ftcn] 0.00102030684982
Target [ftcn] 0.00101894372093
effective [qlco] 0.00100536777311
Average [qnco] 0.00100071964082
Venous malformation [anab] 0.000983045032823
Main [qlco] 0.000980526996565
History [ocdi] 0.000979918990342
Select [acty] 0.000977470448091
Several [qnco] 0.000975511270307
Atrial Fibrillation [patf] 0.000972257397711
Identified [qlco] 0.0009718106068
Elderly [popg] 0.000969193948142
Controlled [ftcn] 0.000967709607334
strategies [menp] 0.000961500903858
Cardiovascular Diseases [dsyn] 0.000957276394761
Medication [phsu] 0.000952032991632
Combined [qlco] 0.000951507250095
Established [qlco] 0.000948847726128
findings [ftcn] 0.000947210566617
Events [evnt] 0.000939237176831
Heart disease [dsyn] 0.000939170820691
Profile [lbpr] 0.000931844460375
search [inpr] 0.000931546881611
Effectiveness [qlco] 0.00092228741241
Literature [inpr] 0.000920596837532
Ratio [qnco] 0.000918693832442
Sclerotherapy [topp] 0.000916442089279
Atherosclerosis [dsyn] 0.000916229916682
Searched [acty] 0.000910931940155
Relationship [qlco] 0.00090923207453
Score [qnco] 0.000909176554955
Update [tmco] 0.000905817159313
C-reactive protein [aapp, imft] 0.000901385719719
Drug [phsu] 0.000900705390351
Adjusted [ftcn] 0.00089671870536
vascular [bpoc] 0.000896578289081
Morbidity [qnco] 0.000889624557582
Body Mass Index [diap] 0.000889287747515
Breast Cancer [neop] 0.000887348469679
Following [tmco] 0.000882114179363
Children [aggp] 0.00088123933246
Future [tmco] 0.000877949384869
Decreased [qnco] 0.00087788130502
rats [mamm] 0.000872673547058
Support [medd] 0.000867431910899
M NOS [aapp, imft] 0.000858534381775
GIVEN [cnce] 0.000848333525213
Measured [qlco] 0.000847879117005
days [tmco] 0.0008432214062
Guidelines [inpr] 0.00084304491486
Burden [idcn] 0.000842365767706
Androgen Deprivation Therapy [topp] 0.000840700341111
APPEAR [qlco] 0.000840019939434
Chronic kidney disease [dsyn] 0.000839397356527
Recommended [idcn] 0.000836358770269
Acute myocardial infarction [dsyn] 0.000836198141251
Required [ftcn] 0.000833257495539
hypertensive [fndg] 0.000823412866582
Six [qnco] 0.000818662547206
Five [qnco] 0.00081764889175
With [qlco] 0.000817142593849
Mechanisms [ftcn] 0.000808986462329
Physical activity [dora] 0.000800067379528
Additional [ftcn] 0.000799757845856
???lead [elii, hops] 0.00079808127217
Independent [idcn] 0.000798013859917
Confidence Intervals [qnco] 0.000796872695372
Make [ftcn] 0.000795756851061
Large [qnco] 0.000789304005929
Multiple [qnco] 0.00078501964893
Single [popg] 0.000784462196957
national [inpr] 0.000780253015185
Irradiation [npop] 0.000775598982478
Likely [qlco] 0.000773494734877
Diagnosed [fndg] 0.000772029405962
Smoking [inbe] 0.000769428425129
chronic [tmco] 0.000768952542459
PLAN [dsyn] 0.00076384543992
Diabetes Mellitus [dsyn] 0.000763778050694
Treatments [topp] 0.000763638857192
Issue [fndg] 0.00076228555629
experience [menp] 0.000754638310485
Local [spco] 0.000753571811892
Characteristics [qlco] 0.000752588726443
Radiation [npop] 0.000743866980718
Previous [tmco] 0.000743284262282
LTD [ortf] 0.000742819719385
Defined [cnce] 0.000742222203026
Benefits [qnco] 0.00074192210982
Alone [qnco] 0.000740191738011
Dyslipidaemia [dsyn] 0.000740124305049
Oral [spco] 0.000738637829344
Hormone Therapy [topp] 0.000735618294491
weeks [tmco] 0.000732261693737
Estimated [qnco] 0.000731776035476
Examined [fndg] 0.000728490838714
patient care [hlca] 0.000726385325885
acute [tmco] 0.000722254273972
Index [inpr] 0.000718463104189
lesions [fndg] 0.000718219304811
Standard [qlco] 0.000716722016321
Report [inpr] 0.000714123940107
Functional [ftcn] 0.000712786247719
Limited [ftcn] 0.000712110025241
Comorbidities [idcn] 0.000708348849358
lowering [spco] 0.000702990234023
Known [qlco] 0.000701470477145
Obesity [dsyn] 0.000697140239678
Life Style [socb] 0.000696756747731
Breast [bpoc] 0.000694626829165
Medical [ftcn] 0.000694156894981
Young [tmco] 0.000693931810686
Imaging [diap] 0.00069169581013
Menopause [phsf] 0.000689394258179
Duration [tmco] 0.000686028230959
Approaches [spco] 0.000685740322247
mg% [qnco] 0.000685473531885
Adults [aggp] 0.000681326049335
Diseases [dsyn] 0.000680224845636
Small [qnco] 0.000678862245263
Various [irda] 0.000677686748122
Well [qlco] 0.000666446388529
Often [tmco] 0.000665385756771
Last [qlco] 0.000664985803307
Address [inpr] 0.000664425093978
Cost Effectiveness [qnco] 0.000664256707846
practice [menp] 0.000663869227227
Vascular Malformations [anab] 0.000663146267853
Awareness [menp] 0.000662895256598
Endothelial [tisu] 0.000662058670056
Post [tmco] 0.000658414134308
mmHg [qnco] 0.000658123665541
deaths [orgf] 0.00065790837647
Currently [tmco] 0.000647500033491
Presented [idcn] 0.000645849365474
Sex [orgf] 0.000643552064828
Central [spco] 0.000643450925956
strategy [menp] 0.000641142641532
Beta-Blockers [phsu] 0.000640304445277
Risks [qlco] 0.00063917964265
Relative [famg] 0.000638763342196
Diet [food] 0.000637310314671
recommendations [idcn] 0.000633843979946
Appropriate [qlco] 0.000632145096429
Revealed [qlco] 0.000631186653934
symptoms [ftcn] 0.000630008803803
Evaluation [ftcn] 0.000629055487165
Relevant [qlco] 0.00062771901803
cardiovascular risk factor [dsyn] 0.000627214545436
Physicians [prog] 0.000623651053571
cardiovascular events [fndg] 0.000622106886515
Values [qlco] 0.000620123104772
Hospital [hcro, mnob] 0.00061718539152
Hospitalization [hlca] 0.000615530194655
Recently [tmco] 0.000614543904522
Take [hlca] 0.000613572865991
Prostate Cancer [neop] 0.00061083978247
Complex [qlco] 0.000609455530075
H+ [elii] 0.00060597364526
Contribute [acty] 0.000604166348879
setting [ftcn] 0.000604136068862
Regression [patf] 0.000600446803427
Novel [tmco] 0.000600429728044
High Density Lipoprotein Cholesterol [bacs, lipd] 0.000600020356585
Damage [inpo] 0.000595319785172
Marker [clna] 0.000592341141301
statistically significant [qnco] 0.000592333339523
Agent [chvf] 0.000590591798781
Medications [phsu] 0.000590394643982
Exercise [dora] 0.000589367409715
reviewed [inpr] 0.000589084124711
Acute Coronary Syndrome [dsyn] 0.000588709307712
Long [qlco] 0.000588267225727
adverse events [fndg] 0.000587962152866
Reducing [qlco] 0.00058770804728
investigated [ftcn] 0.000586482862633
Surgical [hlca] 0.000585839517062
Addition [ftcn] 0.000584402761573
Part [spco] 0.000580554657444
Colorectal Cancer [neop] 0.000578801540775
Consecutive [qlco] 0.000578401088681
Initial [tmco] 0.000577112026846
Program [cnce] 0.000575000093472
Comparison [acty] 0.000572005875121
society [orgt] 0.000571694587678
Optimal [qlco] 0.000570723679405
Occurred [acty] 0.0005674679507
Therapies [topp] 0.00056645211507
Of [spco] 0.000565902662857
secondary [neop] 0.000565580638313
progression [patf] 0.00056386619239
Increasing [ftcn] 0.000563737126212
prognostic [inpr] 0.000563152774203
Meta-Analysis [inpr] 0.000562384992945
Bleeding [patf] 0.000561708831821
mg dl [qnco] 0.000561034080418
Process [bpoc] 0.000559420841636
investigate [ftcn] 0.00055875226446
Obtained [ftcn] 0.000558380658459
Flow [npop] 0.00055778697013
Measures [qnco] 0.000554367125794
Help [socb] 0.000553501456268
Severity [qlco] 0.000550165596822
Normal [qlco] 0.000549589635836
Term [tmco] 0.000547071008804
heart rate [clna] 0.000545529364673
Knowledge [inpr] 0.00054414260883
diabetic [fndg] 0.00054166822276
Status [qlco] 0.000540472959244
Response [orga] 0.000540263402318
LED [mnob] 0.00053947521617
Cost [qnco] 0.000538828666379
Registry [inpr] 0.000532470837411
Plasma [bdsu] 0.000532236359271
Prostate [bpoc] 0.000530714612639
Chemotherapy [topp] 0.0005295860703
Review, Systematic [inpr] 0.000528880775081
Tool [mnob] 0.00052647635024
Primary Prevention [topp] 0.000523054846441
Selection Criteria [qlco] 0.000522064388346
Insulin Resistance [patf] 0.000521288602447
Database [inpr] 0.000517788893866
Leading [tmco] 0.000516590362803
Haemodialysis [topp] 0.000514189815814
Questionnaire [inpr] 0.000513412394484
Guide [prog] 0.000512088358106
Play [dora] 0.000511378717777
Control Group [grup] 0.000510984256549
surveillance [ftcn] 0.000510109442975
Secondary Prevention [topp] 0.000509931898234
Affect [menp] 0.000509176356396
R- [spco] 0.000507975437678
Needed [qlco] 0.000507283198954
function [phsf] 0.000506791312607
Focus [spco] 0.000505672141713
Community [geoa] 0.000503964416774
High dose [qnco] 0.000502663130367
Calculated [ftcn] 0.000502477057946
Action [ftcn] 0.000501727132695
Symptomatic [ftcn] 0.000501597272003
Exposure NOS [inpo] 0.000501425685442
Understanding [menp] 0.000500849065935
Associations [menp] 0.000498099907834
computed tomography [diap] 0.000497330026203
Decade [qnco] 0.000496736446044
Conventional [qlco] 0.000496201003412
peripheral arterial disease [dsyn] 0.000495212015725
Dialysis [npop] 0.000495133809246
Effort [orgf] 0.00049490058163
Improving [qlco] 0.000492763611251
Introduction [hlca] 0.000489805323114
Ischaemic stroke [dsyn] 0.000488178632075
Late [tmco] 0.000486221021431
Dietary [food] 0.000486208107794
Moderate [qlco] 0.000486158240892
Represent [acty] 0.000485698629825
Cholesterol, LDL [bacs, strd] 0.000485693356623
Died [orgf] 0.000483037099493
Low Risk [fndg] 0.000480096045977
Patterns [spco] 0.000480030143545
Activation [acty] 0.000474727969733
Cardiology [bmod] 0.000474315796296
Pain [sosy] 0.000473834225705
Proportion [qnco] 0.000472041869902
Female [fndg] 0.000470031265673
properties [qlco] 0.000468258095941
procedures [inpr] 0.000466732824172
Seven [qnco] 0.000466363893684
techniques [inpr] 0.000465786898199
Good [qlco] 0.000465614008999
Direct [qlco] 0.000464691537226
prospective [resa] 0.000464639892654
Adult [aggp] 0.000464570522927
Onset [qlco] 0.000463630279564
Region [geoa] 0.000463229437343
Relative Risk [qnco] 0.000462275701644
Doses [qnco] 0.000461236457979
Cholesterol [bacs, strd] 0.000460200675146
topic6
treatment [ftcn] 0.00839947145013
P NOS [aapp, imft] 0.00756424615181
Study [mnob] 0.00670725952472
Group [idcn] 0.00562975759406
Methods [inpr] 0.00542668529006
Women [popg] 0.00505250334086
Mortality [qnco] 0.00502029972438
Increased [qnco] 0.0043711944979
CARDIOVASCULAR [bdsy] 0.00379842062076
Cardiovascular disease [dsyn] 0.00372654267895
Conclusions [idcn] 0.00348835512634
Compared [acty] 0.00344553553331
Trial [resa] 0.00329583879011
Stroke [dsyn] 0.00310861919483
effects [qlco] 0.00300540439953
treated [topp] 0.0028981946104
therapy [ftcn] 0.00288450580346
Age [orga] 0.0028620354406
Based [ftcn] 0.00280248543762
Health [idcn] 0.00271740146119
Men [popg] 0.0025200914676
Efficacy [qlco] 0.00236124786841
Hypertension [dsyn] 0.00234954190646
Survival [acty] 0.0022899354087
included [ftcn] 0.00222210432439
Performed [ftcn] 0.00210455055028
months [tmco] 0.00208746859591
Cardiac [bpoc] 0.00206220406588
Management [ocac] 0.00201235975318
Including [ftcn] 0.00198153695913
baseline [bodm] 0.00193120969677
N NOS [aapp, imft] 0.00189288701119
Hormone replacement therapy [topp] 0.00184870756104
Quality [qlco] 0.00183120818976
Dose [qnco] 0.00181758481107
radiotherapy [inpr] 0.00181086196748
Heart [bpoc] 0.00179958091455
Diabetes [dsyn] 0.00179206357413
Reported [inpr] 0.0017878094359
Blood Pressure [orgf] 0.00178031178622
Prevention [topp] 0.00176518430817
Present [qnco] 0.00172002934356
reduction [npop] 0.00166028196811
effective [qlco] 0.00164862598672
Objective [inpr] 0.00164603906378
Observed [ftcn] 0.00163670061265
Therapeutic [topp] 0.00159894067769
IMPACT [gngm] 0.00157807859073
Primary [qlco] 0.00157692576054
Induced [ftcn] 0.0015733946166
Cases [ftcn] 0.00157127633695
Statins [orch, phsu] 0.00156969393222
Complications [patf] 0.00156393520244
participants [popg] 0.00156234347751
Levels [qlco] 0.00150190319911
Association [menp] 0.001492885997
Reserve [acty] 0.00145752792104
Evaluate [ftcn] 0.00144119105081
Range [qnco] 0.00143629854005
Prognostic Factor [clna] 0.0014282773761
Main [qlco] 0.00142706436469
Drug [phsu] 0.00141508975152
risk factors [qnco] 0.00141365797467
Assessed [acty] 0.00140951551655
Benefit [qnco] 0.00139573248463
Specific [qlco] 0.00139471445785
coronary heart disease [dsyn] 0.00139053708791
Hazard Ratio [qnco] 0.00137121500341
Combination [qlco] 0.00133935939819
Subject [grup] 0.0013235603706
placebo [topp] 0.00131844333737
Myocardial Infarction [dsyn] 0.0013096627381
Suggest [idcn] 0.00130812129734
Adjusted [ftcn] 0.00130372154334
Reduced [qlco] 0.0012897441134
Six [qnco] 0.00127768503171
Life [idcn] 0.00125761545897
Atrial Fibrillation [patf] 0.00125698716818
Received [qlco] 0.00125685897358
Survivors [podg] 0.00123437116212
Published [ocac] 0.00122840679208
Available [ftcn] 0.00122330401988
interventions [hlca] 0.00121521235412
Heart failure [dsyn] 0.00120644533881
Care [acty] 0.00120371335079
Medical [ftcn] 0.0011990874443
coronary artery disease [dsyn] 0.00119280058055
practice [menp] 0.00119278528038
Adherence [ftcn] 0.00118740279456
intervention [hlca] 0.00118692899903
PREVENT [phsu] 0.00117834311644
considered [idcn] 0.00117180318436
Odds Ratio [qnco] 0.00116646937638
Several [qnco] 0.00116238603414
Safety [hcpp] 0.00115196480077
Statin [orch, phsu] 0.00114334347575
Radiation [npop] 0.00113887963901
People [popg] 0.00113800815257
Current [tmco] 0.0011373415818
Children [aggp] 0.00113562148288
Controlled [ftcn] 0.00111690854871
weeks [tmco] 0.0010999062395
Receive [qlco] 0.00109465056776
Purpose [ftcn] 0.00108872887238
Improved [qlco] 0.00108850399926
cardiovascular events [fndg] 0.00108728306304
Average [qnco] 0.00108571174061
Target [ftcn] 0.00108212094212
experience [menp] 0.00107894433855
findings [ftcn] 0.00107789768102
Identified [qlco] 0.00107141635089
Physical activity [dora] 0.00106753995847
Score [qnco] 0.00106745296794
Estrogen [horm, phsu, strd] 0.00106502766461
condition [dsyn] 0.00106334895415
Authors [prog] 0.0010626079167
Body Mass Index [diap] 0.00105350532186
Decreased [qnco] 0.00104097980739
Improvement [cnce] 0.0010241030006
Elderly [popg] 0.00102341094885
randomized [resa] 0.00101486573852
High Risk [qlco] 0.0010119519879
Parameters [fndg] 0.00100857428292
Evaluated [ftcn] 0.00100193252845
Adults [aggp] 0.000984470477049
Severe [qlco] 0.000984303078374
Decrease [qlco] 0.000983442059739
search [inpr] 0.000981980430742
Well [qlco] 0.000981645477777
Breast Cancer [neop] 0.000979228270845
mg% [qnco] 0.000954920770157
Often [tmco] 0.000953754927605
objectives [inpr] 0.000948448713491
Irradiation [npop] 0.000944177500217
Effectiveness [qlco] 0.000936687038651
???lead [elii, hops] 0.000934555949502
Article [inpr] 0.000933879898705
Old [tmco] 0.000933654766682
Large [qnco] 0.000931390886186
Drugs [phsu] 0.000931196895061
Approach [spco] 0.000929096296767
Surgery [bmod] 0.000928328702542
Need [qlco] 0.000921363205956
Metabolic syndrome [dsyn] 0.000908450805832
Evaluation [ftcn] 0.000908225021149
Standard [qlco] 0.000906881812096
coronary [bpoc] 0.000905637944209
Damage [inpo] 0.000903227506003
Drug Therapy [topp] 0.000902583228073
Guidelines [inpr] 0.000902085158392
Following [tmco] 0.000901125368015
Androgen Deprivation Therapy [topp] 0.000900258021423
Medication [phsu] 0.000899763662807
Aged [orga] 0.000896912423704
Aspirin [orch, phsu] 0.000896552306631
Conduct [inbe] 0.000886524087871
symptoms [ftcn] 0.000884009845158
Future [tmco] 0.00088225728116
GY [geoa] 0.000881614817377
Required [ftcn] 0.000875848430049
Report [inpr] 0.000871956313445
setting [ftcn] 0.000871339156431
Acute myocardial infarction [dsyn] 0.00086800615152
Treatments [topp] 0.000862806880095
ischaemic heart disease [dsyn] 0.000862524047799
postmenopausal [tmco] 0.000861045121646
Examined [fndg] 0.000859792222166
Previous [tmco] 0.00085685351848
vascular [bpoc] 0.000849873666858
Make [ftcn] 0.000839400487259
Diagnosed [fndg] 0.000838094578661
Sclerotherapy [topp] 0.000837462041802
Likely [qlco] 0.000828831538801
patient care [hlca] 0.000828141366357
Venous malformation [anab] 0.000823265699133
History [ocdi] 0.00082158380633
Menopause [phsf] 0.000815359561918
Obesity [dsyn] 0.000814234733399
Defined [cnce] 0.000811160498649
Heart disease [dsyn] 0.00081109768659
Multiple [qnco] 0.000805688328581
Issue [fndg] 0.000804712224589
Additional [ftcn] 0.00080330031188
Established [qlco] 0.000802195787256
Design [acty] 0.000801435570842
Physicians [prog] 0.000797776762921
Combined [qlco] 0.000797127643541
Burden [idcn] 0.000793031370699
Sex [orgf] 0.000791606214254
Status [qlco] 0.000784117646616
Support [medd] 0.000782982629504
Atherosclerosis [dsyn] 0.000781131886731
Chronic kidney disease [dsyn] 0.000781082609682
In [qnco] 0.000777985696413
Imaging [diap] 0.000773514524625
Needed [qlco] 0.00077292326599
Response [orga] 0.000772766056276
Prostate Cancer [neop] 0.000768329304805
Alone [qnco] 0.000760256420384
society [orgt] 0.000757697424125
Female [fndg] 0.000753854132088
chronic [tmco] 0.000752640156944
Risks [qlco] 0.000750288509213
C-reactive protein [aapp, imft] 0.000749725865731
Assessment [hlca] 0.000747117309953
Various [irda] 0.000744981154663
Morbidity [qnco] 0.000743345659489
Index [inpr] 0.000740261678597
Literature [inpr] 0.000739985384236
Estimated [qnco] 0.000738689142478
Independent [idcn] 0.000734527334211
Appropriate [qlco] 0.000733225410114
Medications [phsu] 0.000729868121826
cardiovascular risk factor [dsyn] 0.000725293793415
acute [tmco] 0.000725228948828
Profile [lbpr] 0.000723238376728
Small [qnco] 0.000721136256467
Single [popg] 0.000718800158345
Cardiovascular Diseases [dsyn] 0.00071634682757
Recommended [idcn] 0.000710599385703
Lipid [lipd] 0.000709524093537
Addition [ftcn] 0.000708196314534
Exercise [dora] 0.000707437604646
Affect [menp] 0.000706433985646
days [tmco] 0.000705603337821
investigated [ftcn] 0.000705330708148
Characteristics [qlco] 0.000704706742525
APPEAR [qlco] 0.000700192663113
Benefits [qnco] 0.000700115746612
recommendations [idcn] 0.000699448651345
Five [qnco] 0.000694812571155
Functional [ftcn] 0.000693623927104
Increasing [ftcn] 0.000692990540516
Cost Effectiveness [qnco] 0.000689432467542
Chemotherapy [topp] 0.000688667326784
With [qlco] 0.000686583597242
deaths [orgf] 0.000681237726625
Limited [ftcn] 0.000675419266937
Obtained [ftcn] 0.00067435250827
Depression [mobd] 0.000673887600794
Known [qlco] 0.000673160197718
Values [qlco] 0.000670055759254
function [phsf] 0.00065957837097
Vascular Malformations [anab] 0.000656591123433
Local [spco] 0.000656274750135
Measures [qnco] 0.000655525483814
Meta-Analysis [inpr] 0.000654722155825
LTD [ortf] 0.000654064550496
Relationship [qlco] 0.000654026946877
Dyslipidaemia [dsyn] 0.00065234673024
prognostic [inpr] 0.000651580056959
Complex [qlco] 0.000649065202974
Plasma [bdsu] 0.000646710536174
national [inpr] 0.00064649390494
strategy [menp] 0.000639773145835
mmHg [qnco] 0.000637589817443
Life Style [socb] 0.000636229454365
Optimal [qlco] 0.000635689906147
Part [spco] 0.000635555872142
Knowledge [inpr] 0.000632633050275
adverse events [fndg] 0.00063237644722
Comorbidities [idcn] 0.000629845089987
Events [evnt] 0.000629309770525
Alternative [cnce] 0.000628417045373
Marker [clna] 0.000624598890586
rats [mamm] 0.00062285685783
prospective [resa] 0.000619537436179
Cardiology [bmod] 0.0006187924168
Searched [acty] 0.000618580241454
Associations [menp] 0.000614952465616
Post [tmco] 0.000613332960046
Update [tmco] 0.000613117066494
Presented [idcn] 0.00061272387403
Oral [spco] 0.000612516170452
Novel [tmco] 0.000609577588286
Stable [qlco] 0.000608201883897
Exposure NOS [inpo] 0.00060702827069
hypertensive [fndg] 0.000605954481918
Ratio [qnco] 0.000604021700963
Hospital [hcro, mnob] 0.000600626786656
reviewed [inpr] 0.00059980164979
secondary [neop] 0.000599617587598
Late [tmco] 0.000594925269091
Action [ftcn] 0.000594764763619
Address [inpr] 0.000593524234531
lesions [fndg] 0.000593068950556
Relative [famg] 0.000591172251719
activity [dora] 0.000589227765579
Guide [prog] 0.000589137595051
Last [qlco] 0.000587186348351
Moderate [qlco] 0.000586252254285
Challenge [clna] 0.000584878045172
Measured [qlco] 0.00058414214869
Countries [geoa] 0.000582859579433
Central [spco] 0.000581739588064
Information [idcn] 0.000579817166347
Inflammation [patf] 0.000575653809078
Control Group [grup] 0.000572010310007
Discharge [bdsu] 0.000571249713634
Select [acty] 0.000570315239297
Mechanisms [ftcn] 0.000568837779258
Agent [chvf] 0.000567651457465
Diseases [dsyn] 0.000565750075687
Flow [npop] 0.000565699806915
Long [qlco] 0.000565174998866
Tool [mnob] 0.000563437067729
strategies [menp] 0.000562308734006
Metabolic [ftcn] 0.000559473295337
Prescription [hlca] 0.000558717518489
Duration [tmco] 0.000557879165195
Initial [tmco] 0.000555972338654
High Density Lipoprotein Cholesterol [bacs, lipd] 0.000555093958037
GIVEN [cnce] 0.000554966125694
Calculated [ftcn] 0.000554219051157
Beta-Blockers [phsu] 0.000552915256779
Confidence Intervals [qnco] 0.00054961978111
lowering [spco] 0.000545559394742
Occurred [acty] 0.000545155158914
Young [tmco] 0.000545116757463
Link [inpr] 0.00054321621803
atorvastatin [orch, phsu] 0.000542984450576
Comparison [acty] 0.000541084676849
Community [geoa] 0.000541049622109
Diet [food] 0.00054086067371
Awareness [menp] 0.000540753353555
investigate [ftcn] 0.000539705939611
Consecutive [qlco] 0.000537848862918
Of [spco] 0.000537608735569
Pulmonary arterial hypertension [dsyn] 0.000534458429886
Represent [acty] 0.000532838407715
Play [dora] 0.000531621428871
Secondary Prevention [topp] 0.000529831019942
Onset [qlco] 0.00052873449452
Sample [sbst] 0.000527807544148
variables [qlco] 0.000527492700926
Order [inpr] 0.000526754473821
Hospitalization [hlca] 0.000525624070493
Variability [cnce] 0.000522322940973
Hormone Therapy [topp] 0.000522063363006
Clinical Trials [resa] 0.000521600177575
Stage [tmco] 0.000518823605396
Concern [idcn] 0.000518047618914
H+ [elii] 0.000517589667641
Smoking [inbe] 0.000516304345702
Active [ftcn] 0.000511159149338
Understanding [menp] 0.000511037048744
Short-term [tmco] 0.000510836858338
Rheumatic Heart Disease [dsyn] 0.00051058304661
Relevant [qlco] 0.000509930255702
System [ftcn] 0.000508087958001
Ischaemic [ftcn] 0.000506963347883
Decade [qnco] 0.000506423118422
Dependent [qlco] 0.000504986350694
Surgical [hlca] 0.000503809245603
Program [cnce] 0.000502861568531
peripheral arterial disease [dsyn] 0.000498877774535
Cost [qnco] 0.000497417351713
Percutaneous [spco] 0.000497136474254
Lung Cancer [neop] 0.000495123149867
Inflammatory [ftcn] 0.00049509030929
Endothelial [tisu] 0.000494734438711
Test [lbpr] 0.000494123087145
Recently [tmco] 0.000493411705755
LED [mnob] 0.00049268071627
Symptomatic [ftcn] 0.000491172255132
Regression [patf] 0.000489959803831
Direct [qlco] 0.000489654956178
Gender [orga] 0.000488109348301
side effects [ftcn] 0.000487426094836
Proportion [qnco] 0.000487372658475
Leading [tmco] 0.000485490060656
Take [hlca] 0.000484208735616
matched [resa] 0.000484056446989
Niacin [orch, phsu, vita] 0.000481469597071
Low dose [qnco] 0.000481266204753
Congenital heart disease [cgab, dsyn] 0.000480959774309
Oxidative Stress [comd] 0.000480425153955
Total Cholesterol [lbpr] 0.000479704931668
Primary Prevention [topp] 0.000479363776604
Reducing [qlco] 0.000478685051082
Arterial [bpoc] 0.000478644526494
Therapies [topp] 0.000477262335159
Critical [qlco] 0.000476657808007
Segment [spco] 0.000475410955733
criteria [inpr] 0.000474784560207
majority [socb] 0.000474460349715
Elevated [qlco] 0.000474085363917
Class [inpr] 0.000473803347285
Doses [qnco] 0.000473420735993
Measure [qnco] 0.000473307191093
Improving [qlco] 0.000472111447883
Database [inpr] 0.000470532531496
Process [bpoc] 0.000468638981163
Few [qnco] 0.000468590357475
Low Risk [fndg] 0.000467115624673
Pre-operative [tmco] 0.000465533643426
Center [spco] 0.000465055357636
Currently [tmco] 0.000464884331432
Contribute [acty] 0.000463915141927
Diabetes Mellitus [dsyn] 0.000463747499707
topic7
P NOS [aapp, imft] 0.00952936088779
Study [mnob] 0.00829802095081
Cardiovascular disease [dsyn] 0.00766015812378
treatment [ftcn] 0.00729238991561
Women [popg] 0.00568586260636
Mortality [qnco] 0.00549697561054
Group [idcn] 0.00521066656308
Methods [inpr] 0.00477690885417
Trial [resa] 0.00450879759361
Increased [qnco] 0.0044689391964
Age [orga] 0.00426449307789
CARDIOVASCULAR [bdsy] 0.00390899338914
Compared [acty] 0.00329603259474
Conclusions [idcn] 0.00306527459244
effects [qlco] 0.00285914078972
treated [topp] 0.00276794028202
therapy [ftcn] 0.00267776630024
Hypertension [dsyn] 0.002564291649
participants [popg] 0.00256205243775
N NOS [aapp, imft] 0.00250561195696
Based [ftcn] 0.00247972801822
radiotherapy [inpr] 0.00246300272083
Cardiac [bpoc] 0.00245222116586
Prevention [topp] 0.0023836011128
included [ftcn] 0.00223393026619
Stroke [dsyn] 0.00219856838854
Quality [qlco] 0.00212485067803
Diabetes [dsyn] 0.00208962847211
Levels [qlco] 0.00206271205786
risk factors [qnco] 0.00201861163882
months [tmco] 0.00201574285528
Specific [qlco] 0.00201433202847
Heart [bpoc] 0.00199433800552
Men [popg] 0.00199361130955
Hormone replacement therapy [topp] 0.00187550022529
Suggest [idcn] 0.00186531625646
Health [idcn] 0.00186301798405
Efficacy [qlco] 0.00182940139617
Survival [acty] 0.00181322185229
Observed [ftcn] 0.00170717266567
placebo [topp] 0.00170405078344
Association [menp] 0.0017035760865
Dose [qnco] 0.00170190870286
Objective [inpr] 0.00167167937749
reduction [npop] 0.00165068988267
baseline [bodm] 0.00160377544649
coronary heart disease [dsyn] 0.00159596994713
Management [ocac] 0.00158176159564
Blood Pressure [orgf] 0.0015794647375
Performed [ftcn] 0.00155566065289
Cases [ftcn] 0.00153806478581
Assessed [acty] 0.00153310389581
Including [ftcn] 0.00151763615126
Statins [orch, phsu] 0.00147275587955
Surgery [bmod] 0.00142905887133
cardiovascular events [fndg] 0.00141093412414
Reserve [acty] 0.00140398835865
Improved [qlco] 0.00139916081078
Body Mass Index [diap] 0.00136545570674
Present [qnco] 0.00136162827622
interventions [hlca] 0.00135783828295
IMPACT [gngm] 0.0013492944357
Lipid [lipd] 0.00134827357043
Care [acty] 0.0013467874679
Children [aggp] 0.00133799376777
Induced [ftcn] 0.0013087544677
Breast Cancer [neop] 0.0012974731111
Identified [qlco] 0.00128755032505
Radiation [npop] 0.00127541889086
coronary artery disease [dsyn] 0.00126806338495
Controlled [ftcn] 0.00126183598916
Authors [prog] 0.00126174767927
Reduced [qlco] 0.00125571350407
Evaluate [ftcn] 0.00124998374899
Conduct [inbe] 0.00124467014785
Chronic kidney disease [dsyn] 0.00122233753211
Complications [patf] 0.00122009658545
Need [qlco] 0.001201304386
Life [idcn] 0.00119856337625
Design [acty] 0.00119795746807
intervention [hlca] 0.00119567473411
effective [qlco] 0.00119157696076
Receive [qlco] 0.00117909836237
Subject [grup] 0.00116248944545
Therapeutic [topp] 0.00114904123261
Reported [inpr] 0.00114536438501
Assessment [hlca] 0.00114079098865
randomized [resa] 0.00113957741679
Drugs [phsu] 0.0011371143366
Published [ocac] 0.00113702690349
Adjusted [ftcn] 0.0011299084424
Available [ftcn] 0.00112778160331
Improvement [cnce] 0.0011260355984
Current [tmco] 0.00112186954185
Limited [ftcn] 0.00111859480041
Metabolic syndrome [dsyn] 0.00111317337351
Evaluated [ftcn] 0.00110984111217
High Risk [qlco] 0.00110907214884
History [ocdi] 0.00109854986686
Main [qlco] 0.00109601652176
condition [dsyn] 0.00108803603674
Prognostic Factor [clna] 0.00108801369166
Dyslipidaemia [dsyn] 0.00108550697936
Old [tmco] 0.00108363750313
Atherosclerosis [dsyn] 0.00107173790946
Atrial Fibrillation [patf] 0.00106916907747
Hazard Ratio [qnco] 0.00106577102092
Statin [orch, phsu] 0.0010641121123
Myocardial Infarction [dsyn] 0.00106182516969
Five [qnco] 0.00104924527886
Received [qlco] 0.00104812800665
Survivors [podg] 0.00104687340678
Obesity [dsyn] 0.00104273751008
postmenopausal [tmco] 0.00104080359403
Combined [qlco] 0.00104053652813
Estrogen [horm, phsu, strd] 0.00104012534609
Range [qnco] 0.00103947666749
Severe [qlco] 0.00103694970403
Odds Ratio [qnco] 0.00103354758355
Primary [qlco] 0.00103324616665
Score [qnco] 0.0010312606366
Support [medd] 0.00102454719277
findings [ftcn] 0.00102340465114
Oral [spco] 0.00102305048402
Effectiveness [qlco] 0.00101795571123
Likely [qlco] 0.00101566330596
C-reactive protein [aapp, imft] 0.00101429974955
Combination [qlco] 0.00100838699108
Androgen Deprivation Therapy [topp] 0.00100471099472
Examined [fndg] 0.000999881887438
Elderly [popg] 0.000994933020708
Safety [hcpp] 0.000994512702947
Approach [spco] 0.00098717480303
Heart failure [dsyn] 0.000980492114784
Drug [phsu] 0.000970103729984
Purpose [ftcn] 0.000966366161269
Large [qnco] 0.000964348346151
Established [qlco] 0.000963763899264
strategies [menp] 0.000963484198646
Benefit [qnco] 0.000954268138502
Profile [lbpr] 0.000954236019776
Article [inpr] 0.000953543187224
Often [tmco] 0.000945728648542
Well [qlco] 0.000945719439709
experience [menp] 0.00093903733618
Independent [idcn] 0.000923759790531
Searched [acty] 0.000923742683505
Parameters [fndg] 0.000922170734044
People [popg] 0.000921553797272
Literature [inpr] 0.000915233720678
Medication [phsu] 0.000906605117467
Estimated [qnco] 0.000906588200647
PREVENT [phsu] 0.000901830896591
Decrease [qlco] 0.000901371337836
setting [ftcn] 0.000898857757752
Guidelines [inpr] 0.000896021657025
Measured [qlco] 0.000895810395184
Small [qnco] 0.000893617005685
Sclerotherapy [topp] 0.000893158097391
Mechanisms [ftcn] 0.000892366750352
Known [qlco] 0.000890735220429
Appropriate [qlco] 0.000883939333451
Morbidity [qnco] 0.000883566187662
practice [menp] 0.000881005703214
weeks [tmco] 0.000879027081454
Average [qnco] 0.000878280381209
Diagnosed [fndg] 0.000874970308034
considered [idcn] 0.000873293961037
objectives [inpr] 0.000873237285197
Aged [orga] 0.000865825173428
ischaemic heart disease [dsyn] 0.000864156263152
search [inpr] 0.000862337260915
Standard [qlco] 0.000860713554079
national [inpr] 0.000857741072789
Following [tmco] 0.000856380873182
???lead [elii, hops] 0.000849926344389
chronic [tmco] 0.000849408235663
Report [inpr] 0.000844470612594
M NOS [aapp, imft] 0.000840152250938
Venous malformation [anab] 0.00083839017624
Heart disease [dsyn] 0.000837563282447
Sex [orgf] 0.000837147466225
Alone [qnco] 0.000836646945476
Update [tmco] 0.000835670073527
Benefits [qnco] 0.000832044874197
Confidence Intervals [qnco] 0.000830419654138
Adherence [ftcn] 0.000827212413414
Optimal [qlco] 0.000826620576771
Irradiation [npop] 0.000826094498788
Decreased [qnco] 0.00082554880645
Needed [qlco] 0.000819055661253
Drug Therapy [topp] 0.000818693591775
Required [ftcn] 0.000815384796201
Acute myocardial infarction [dsyn] 0.000812195060114
Characteristics [qlco] 0.000808497428485
deaths [orgf] 0.000806920372714
investigate [ftcn] 0.000806443212325
Medical [ftcn] 0.000802888801822
Physical activity [dora] 0.000801942263806
Physicians [prog] 0.000795574627412
LTD [ortf] 0.000794429325997
Several [qnco] 0.000793638167952
rats [mamm] 0.000793347695614
Initial [tmco] 0.000784772015415
symptoms [ftcn] 0.000784731059072
Central [spco] 0.000782789766528
In [qnco] 0.000779866700565
System [ftcn] 0.000771348251371
Hormone Therapy [topp] 0.000769988023739
With [qlco] 0.000768223367565
Beta-Blockers [phsu] 0.000766848795613
Previous [tmco] 0.000764595776047
Events [evnt] 0.000758484565093
Duration [tmco] 0.000757481546352
Multiple [qnco] 0.000755438798189
Adults [aggp] 0.00075317717254
Index [inpr] 0.000749275710059
APPEAR [qlco] 0.000746773036975
Issue [fndg] 0.000743728325452
Hospital [hcro, mnob] 0.000737767622873
Affect [menp] 0.000737312721587
Burden [idcn] 0.000736982459894
progression [patf] 0.000735054800915
cardiovascular risk factor [dsyn] 0.00073301455891
mg dl [qnco] 0.000730831528679
GY [geoa] 0.000730373972474
Associations [menp] 0.000726962108457
investigated [ftcn] 0.000726475159451
Relationship [qlco] 0.000726449213695
Target [ftcn] 0.000724842963834
Additional [ftcn] 0.00072347465878
Life Style [socb] 0.00071295092835
Reducing [qlco] 0.00071227984723
Part [spco] 0.000708985354808
Total Cholesterol [lbpr] 0.000705843971431
Long [qlco] 0.000703503596676
Single [popg] 0.000702243620676
Local [spco] 0.000702044426266
Damage [inpo] 0.000701399852648
Treatments [topp] 0.000700366166399
Risks [qlco] 0.000699924798308
peripheral arterial disease [dsyn] 0.000697158526462
strategy [menp] 0.000694145880275
days [tmco] 0.000690013318603
vascular [bpoc] 0.000689084902543
coronary [bpoc] 0.000685853613036
Prostate Cancer [neop] 0.00068403855743
Values [qlco] 0.000681689970207
Concern [idcn] 0.000678315846328
Therapies [topp] 0.000675591738147
Six [qnco] 0.00067332701068
Young [tmco] 0.000669289716346
Make [ftcn] 0.00066823561832
Recommended [idcn] 0.00066773682031
Diabetes Mellitus [dsyn] 0.000664336144676
Defined [cnce] 0.000660767597229
Select [acty] 0.000658330110565
Discharge [bdsu] 0.000656974430063
Knowledge [inpr] 0.000652986683336
Female [fndg] 0.000651498631337
GIVEN [cnce] 0.000651187741853
Cardiovascular Diseases [dsyn] 0.000645508720296
Program [cnce] 0.00064462441901
mg% [qnco] 0.000641946670608
Marker [clna] 0.000632434125811
prospective [resa] 0.000631895316039
Exposure NOS [inpo] 0.00063175541945
Leading [tmco] 0.000628845783957
Novel [tmco] 0.000622165183263
Countries [geoa] 0.00061981825961
Represent [acty] 0.000618499268025
Menopause [phsf] 0.000616084343892
Plasma [bdsu] 0.000614656302523
Measures [qnco] 0.000612653972652
Complex [qlco] 0.000611400175742
Primary Prevention [topp] 0.000610213636921
Extracted [topp] 0.000610187796982
adverse events [fndg] 0.000608591702437
Calculated [ftcn] 0.000607914920035
Response [orga] 0.000603921026347
Address [inpr] 0.000603520018035
Smoking [inbe] 0.000603483572406
Cost Effectiveness [qnco] 0.000601528847337
Comparison [acty] 0.000601211585311
Future [tmco] 0.000600803885691
lowering [spco] 0.000600710451119
Addition [ftcn] 0.000600664783733
Various [irda] 0.00059303364388
Vascular Malformations [anab] 0.000592385624755
Guide [prog] 0.000591280064723
Ratio [qnco] 0.000589609335639
Diseases [dsyn] 0.000589275056484
Low Risk [fndg] 0.000585805106787
Area [geoa] 0.000581990621616
Imaging [diap] 0.000579220430463
Questionnaire [inpr] 0.00057485066694
Low dose [qnco] 0.000574741478319
R- [spco] 0.000574634373824
Congenital heart disease [cgab, dsyn] 0.000574511440555
Regression [patf] 0.000572739788978
Colorectal Cancer [neop] 0.000570057627161
Normal [qlco] 0.000568403304743
Of [spco] 0.000566528911726
Chemotherapy [topp] 0.000566197704715
Currently [tmco] 0.000565778802696
Review, Systematic [inpr] 0.000562688624516
Exercise [dora] 0.00056135151413
Meta-Analysis [inpr] 0.000561313086029
Haemodialysis [topp] 0.000557788513681
recommendations [idcn] 0.000554161784558
Comorbidities [idcn] 0.00055313716886
Surgical [hlca] 0.000551721313873
reviewed [inpr] 0.000551488584352
Status [qlco] 0.000550584873489
Adult [aggp] 0.000549522242753
PLAN [dsyn] 0.000548648565008
Awareness [menp] 0.000547751396637
Functional [ftcn] 0.000546794626453
Ischaemic stroke [dsyn] 0.000546730055409
Dependent [qlco] 0.000546693988598
Last [qlco] 0.000546337554135
Collected [idcn] 0.000545163474465
Inflammation [patf] 0.00054279388865
function [phsf] 0.000542070076873
Bias [idcn] 0.000539826029118
lesions [fndg] 0.000539368673922
Cells [cell] 0.00053934201278
Endothelial [tisu] 0.0005384103433
Increasing [ftcn] 0.000537616228925
Aspirin [orch, phsu] 0.000537309677926
Revealed [qlco] 0.000533908579495
variables [qlco] 0.000533871823845
Late [tmco] 0.000532484921649
Medications [phsu] 0.000532369011697
Correlation [qlco] 0.000532330277124
prognostic [inpr] 0.000530649863474
Obtained [ftcn] 0.000530442786529
randomized controlled trials [inpr, resa] 0.000530248146312
Flow [npop] 0.000529652118103
Secondary Prevention [topp] 0.000527909012499
Acute Coronary Syndrome [dsyn] 0.000525857552505
Evaluation [ftcn] 0.000521291885944
Users [humn] 0.000519697832884
Take [hlca] 0.000519371681249
Prescription [hlca] 0.00051692907875
statistically significant [qnco] 0.000516272670824
society [orgt] 0.000515924898829
Died [orgf] 0.000514150480568
Cardiology [bmod] 0.000511671893372
Fatal [qlco] 0.000510770839819
Programs [inpr] 0.00050824111884
Data Collection [resa] 0.000505789206511
Moderate [qlco] 0.000502520042162
High dose [qnco] 0.000501060161946
Relevant [qlco] 0.000498947249805
measurements [ftcn] 0.000498846292872
Sample [sbst] 0.000498832607771
Information [idcn] 0.000498569824698
Play [dora] 0.000498263581626
Seen [qlco] 0.000498067094024
Presented [idcn] 0.000497665400807
Systolic blood pressure [clna] 0.000497486856345
H+ [elii] 0.000493278901637
Altered [ftcn] 0.000492800219898
Survey [inpr] 0.00049181392545
computed tomography [diap] 0.000491668302385
Doses [qnco] 0.000490482640258
Post [tmco] 0.000489739027914
Frequently [tmco] 0.000487953136547
Hospitalization [hlca] 0.000487724397385
Daily [tmco] 0.000487573157685
Approaches [spco] 0.000485631821216
Contribute [acty] 0.000485062993456
Metabolic [ftcn] 0.000484771269449
lack [qlco] 0.000482628484869
Renal [bpoc] 0.000481093276194
Direct [qlco] 0.000479642472468
Measure [qnco] 0.000478884959191
secondary [neop] 0.000476961693735
Term [tmco] 0.000475321258741
Regular [qlco] 0.000475126013986
Control Group [grup] 0.000474003765378
activity [dora] 0.000473066777193
hypertensive [fndg] 0.000472442512086
acute [tmco] 0.000472270030968
Obese [dsyn] 0.000471529288956
Bleeding [patf] 0.000468961031572
Proportion [qnco] 0.000468829416531
Recently [tmco] 0.000468697112759
occurrence [ftcn] 0.000468219149578
retrospective [resa] 0.000467446284449
Understanding [menp] 0.000467156416327
Gender [orga] 0.000465408417829
Agent [chvf] 0.00046399989731
Access [spco] 0.000463273055767
Severity [qlco] 0.000463064158152
majority [socb] 0.000460839075839
Decade [qnco] 0.000460065617719
Multi [qnco] 0.000459589484638
LED [mnob] 0.000459529062839
topic8
treatment [ftcn] 0.0114432389109
P NOS [aapp, imft] 0.00884603535835
Women [popg] 0.00691197265016
Study [mnob] 0.00593575414191
Group [idcn] 0.00567582576395
Compared [acty] 0.0046811903362
Methods [inpr] 0.00462201912436
Trial [resa] 0.00460811497759
Cardiovascular disease [dsyn] 0.00459423868403
Mortality [qnco] 0.00385563873658
Stroke [dsyn] 0.00314269130965
effects [qlco] 0.00312191555427
included [ftcn] 0.00311359804458
therapy [ftcn] 0.00309055826669
Age [orga] 0.00301758916849
CARDIOVASCULAR [bdsy] 0.00285398158516
Based [ftcn] 0.00279396749657
Conclusions [idcn] 0.00272129669885
treated [topp] 0.00271181791059
Diabetes [dsyn] 0.00264160756457
Health [idcn] 0.00259091016452
Survival [acty] 0.00252456850859
Hypertension [dsyn] 0.00250384815926
months [tmco] 0.00241100751071
Heart [bpoc] 0.0023373374797
Increased [qnco] 0.00233579906101
Dose [qnco] 0.00229905008054
participants [popg] 0.00227826345861
Association [menp] 0.0021687523313
Cases [ftcn] 0.00215437697214
Suggest [idcn] 0.00214329877985
risk factors [qnco] 0.00211733637286
Including [ftcn] 0.00197046092962
N NOS [aapp, imft] 0.00195948872279
Performed [ftcn] 0.00188871610766
postmenopausal [tmco] 0.00188039105025
Care [acty] 0.00181840647615
Management [ocac] 0.00175092481102
coronary heart disease [dsyn] 0.00171086896747
Myocardial Infarction [dsyn] 0.00170998505913
Men [popg] 0.00169818050602
Observed [ftcn] 0.00168524682775
Quality [qlco] 0.00164785383194
radiotherapy [inpr] 0.00164667982636
Efficacy [qlco] 0.00164483045145
Present [qnco] 0.00164408606985
Prevention [topp] 0.00163257343702
Evaluate [ftcn] 0.00162983665584
IMPACT [gngm] 0.00162519060275
Blood Pressure [orgf] 0.00162177766538
Hazard Ratio [qnco] 0.00158986937386
Objective [inpr] 0.00156484388338
Drug [phsu] 0.00153461671035
Complications [patf] 0.00153293394064
Cardiac [bpoc] 0.00152971078046
Receive [qlco] 0.00152497687716
High Risk [qlco] 0.0015057646623
intervention [hlca] 0.0015050763642
Range [qnco] 0.00150143147285
Levels [qlco] 0.00149843779997
reduction [npop] 0.00146901112276
interventions [hlca] 0.0014382305359
Reduced [qlco] 0.00143727635164
Benefit [qnco] 0.00142368499898
Primary [qlco] 0.00141732389709
Identified [qlco] 0.00138502947662
Reserve [acty] 0.00137655646419
Statins [orch, phsu] 0.00136830734157
Breast Cancer [neop] 0.00136652388357
Available [ftcn] 0.00136294451207
Authors [prog] 0.00135322949761
Published [ocac] 0.00135170487724
Specific [qlco] 0.00135119741585
Prognostic Factor [clna] 0.00133233058764
Hormone replacement therapy [topp] 0.00132366963081
Induced [ftcn] 0.00130818766187
Evaluated [ftcn] 0.00130344161241
baseline [bodm] 0.00128663612552
History [ocdi] 0.00127974536361
Received [qlco] 0.00127960854631
Assessed [acty] 0.00127825486909
Large [qnco] 0.00127120821191
Old [tmco] 0.00126944312827
effective [qlco] 0.00126521595741
Decreased [qnco] 0.00125833187121
Surgery [bmod] 0.00124200033814
Children [aggp] 0.0012191719848
Atrial Fibrillation [patf] 0.0012174937813
Reported [inpr] 0.00120577224925
coronary artery disease [dsyn] 0.00120071315466
Therapeutic [topp] 0.00119462504126
considered [idcn] 0.00119302219298
Events [evnt] 0.00118647819833
Venous malformation [anab] 0.00118500138558
Drug Therapy [topp] 0.00117768286012
Safety [hcpp] 0.00117175711203
Confidence Intervals [qnco] 0.0011647353999
strategies [menp] 0.00115254983678
condition [dsyn] 0.00114959720267
Parameters [fndg] 0.00114374140585
Life [idcn] 0.00114076506883
Approach [spco] 0.0011389835776
cardiovascular events [fndg] 0.00111782046291
Sclerotherapy [topp] 0.00111034501583
Atherosclerosis [dsyn] 0.00110977530564
Main [qlco] 0.00110201497977
Subject [grup] 0.00110196915145
Current [tmco] 0.00110069882526
Likely [qlco] 0.00109354590677
Imaging [diap] 0.00109175142115
Controlled [ftcn] 0.00108490305865
Need [qlco] 0.00107252743059
Support [medd] 0.00106096707096
Defined [cnce] 0.00105806981952
symptoms [ftcn] 0.00105407150515
Severe [qlco] 0.00105241681405
Radiation [npop] 0.00104987319139
People [popg] 0.00104221625742
Design [acty] 0.00104093114733
setting [ftcn] 0.00103767043165
Often [tmco] 0.00103679021753
Conduct [inbe] 0.00102083640044
Statin [orch, phsu] 0.0010152879369
Elderly [popg] 0.00101511423031
Diagnosed [fndg] 0.00100874865773
days [tmco] 0.0010083388194
Guidelines [inpr] 0.00100643621351
placebo [topp] 0.00100643597646
Average [qnco] 0.00100547252448
Previous [tmco] 0.00100205021312
Survivors [podg] 0.000996534220887
Menopause [phsf] 0.000983072326188
Improvement [cnce] 0.000982288432399
Purpose [ftcn] 0.000975883817683
Medical [ftcn] 0.000975500243323
Irradiation [npop] 0.000972138479692
Characteristics [qlco] 0.000952907057584
findings [ftcn] 0.000950109357519
Assessment [hlca] 0.00094893137227
Improved [qlco] 0.000939017405184
Heart failure [dsyn] 0.000937297913026
Treatments [topp] 0.000935428530566
Effectiveness [qlco] 0.000933366908856
Five [qnco] 0.000932927046059
Body Mass Index [diap] 0.000932006836794
Drugs [phsu] 0.000925185885175
Estrogen [horm, phsu, strd] 0.000924593628324
Chronic kidney disease [dsyn] 0.000919229052041
Independent [idcn] 0.000917427922736
acute [tmco] 0.000916998598892
randomized [resa] 0.000915864224747
Odds Ratio [qnco] 0.000915364969355
Various [irda] 0.00091009027181
Adherence [ftcn] 0.000908545447766
In [qnco] 0.00090231762105
Adjusted [ftcn] 0.000901602219292
Estimated [qnco] 0.000897754102122
coronary [bpoc] 0.000896063849712
vascular [bpoc] 0.000894027104728
Established [qlco] 0.0008931922769
search [inpr] 0.000890207999828
Lipid [lipd] 0.000886876867793
Target [ftcn] 0.000883310466099
Acute myocardial infarction [dsyn] 0.000882611003664
Morbidity [qnco] 0.000882378377344
Several [qnco] 0.000881974589521
Evaluation [ftcn] 0.000876617536725
national [inpr] 0.000876057082301
rats [mamm] 0.000865504190434
function [phsf] 0.000864492206834
Aspirin [orch, phsu] 0.000863002290402
lesions [fndg] 0.000862681760793
Six [qnco] 0.00086244498814
Obesity [dsyn] 0.000861102652316
With [qlco] 0.000852600262676
Score [qnco] 0.000852259541876
Make [ftcn] 0.000850011282156
Standard [qlco] 0.000840570496203
GY [geoa] 0.000840199717019
Marker [clna] 0.000838937165253
Small [qnco] 0.000838262353173
Article [inpr] 0.000820839734381
Optimal [qlco] 0.000819857320672
Combination [qlco] 0.000808476111748
Index [inpr] 0.000807164995796
chronic [tmco] 0.000799895104694
Oral [spco] 0.000799551681338
Measured [qlco] 0.000796181802774
practice [menp] 0.000789842283856
objectives [inpr] 0.000784106480186
Limited [ftcn] 0.000783199189429
Take [hlca] 0.000778489501188
hypertensive [fndg] 0.000777408356457
Searched [acty] 0.000777321130535
Well [qlco] 0.000775115099791
Last [qlco] 0.000772611061015
Increasing [ftcn] 0.000765023961582
Following [tmco] 0.000762794197334
society [orgt] 0.000762674931449
Values [qlco] 0.000755768785866
Recommended [idcn] 0.00075431929901
Report [inpr] 0.000750205106863
Status [qlco] 0.000749712073685
mmHg [qnco] 0.000747455160413
Needed [qlco] 0.000746052403658
Life Style [socb] 0.000745046235337
Combined [qlco] 0.000739158300284
Aged [orga] 0.000734827978953
Medication [phsu] 0.000734327042685
deaths [orgf] 0.000734322371967
Adults [aggp] 0.000730541959136
experience [menp] 0.000726521531931
adverse events [fndg] 0.000725887709614
Reducing [qlco] 0.000725858302881
ischaemic heart disease [dsyn] 0.000725827294337
investigated [ftcn] 0.000718292265854
System [ftcn] 0.000715806927686
Doses [qnco] 0.000712814972494
Therapies [topp] 0.000712439300954
Issue [fndg] 0.000706981748056
Surgical [hlca] 0.000706537876746
mg% [qnco] 0.000706312082976
Ratio [qnco] 0.000703507485653
investigate [ftcn] 0.000702491422127
Examined [fndg] 0.000698116721239
Mechanisms [ftcn] 0.000697981795225
Exercise [dora] 0.00069407731964
Relationship [qlco] 0.00069138162021
Appropriate [qlco] 0.00068903217292
Damage [inpo] 0.000686026994392
Select [acty] 0.000685610515374
Obtained [ftcn] 0.000685507879062
Occurred [acty] 0.000684373172846
Central [spco] 0.000684086943805
Alone [qnco] 0.000682718591412
Additional [ftcn] 0.000682584960037
Known [qlco] 0.000678940645275
PREVENT [phsu] 0.000675009912282
progression [patf] 0.000674032110813
Risks [qlco] 0.000673907569694
patient care [hlca] 0.000670548651036
Prostate Cancer [neop] 0.000669483268179
Literature [inpr] 0.000663651395236
C-reactive protein [aapp, imft] 0.000663254748799
Focus [spco] 0.000663129774694
PLAN [dsyn] 0.000662894422491
Multiple [qnco] 0.000662863116054
Dyslipidaemia [dsyn] 0.000661546711532
H+ [elii] 0.000661326914734
Metabolic syndrome [dsyn] 0.000660606859311
Cardiovascular Diseases [dsyn] 0.000657142360262
secondary [neop] 0.000654941886414
Comparison [acty] 0.000650767484686
Functional [ftcn] 0.000650619436181
APPEAR [qlco] 0.000649482198411
weeks [tmco] 0.000648590684135
recommendations [idcn] 0.000645738750716
Cost Effectiveness [qnco] 0.000645633768727
Long [qlco] 0.000644728180795
Hospitalization [hlca] 0.000641211658772
Decade [qnco] 0.000636138025801
Local [spco] 0.00063589667697
Medications [phsu] 0.000630239455316
Risk Ratios [qnco] 0.000627507285739
Agent [chvf] 0.000626490580213
Of [spco] 0.000626307373472
Information [idcn] 0.000626306297327
Androgen Deprivation Therapy [topp] 0.00062365120667
Post [tmco] 0.000622831507315
???lead [elii, hops] 0.000620231533165
Registry [inpr] 0.00061722310926
Moderate [qlco] 0.000614121129888
peripheral arterial disease [dsyn] 0.000613823997709
Sex [orgf] 0.000613583124608
Vascular Malformations [anab] 0.000612933253411
Improving [qlco] 0.00061276426808
Renal [bpoc] 0.00060892163083
mg dl [qnco] 0.000608432996769
Burden [idcn] 0.000605459020422
Response [orga] 0.000602066534227
Decrease [qlco] 0.00060120608861
Breast [bpoc] 0.000600571181705
Heart disease [dsyn] 0.000597518251636
Associations [menp] 0.0005943654385
Measures [qnco] 0.0005941701974
Physical activity [dora] 0.00059077417612
Future [tmco] 0.00059032796908
strategy [menp] 0.000590280844223
Diseases [dsyn] 0.000589565413499
paediatric [bmod] 0.000588072054207
Acute Coronary Syndrome [dsyn] 0.000583131396161
size [spco] 0.00058178658253
Low Risk [fndg] 0.000581063464331
Affect [menp] 0.000579504061787
Plasma [bdsu] 0.000578127805004
Meta-Analysis [inpr] 0.000577479583748
Part [spco] 0.000574083732974
Presented [idcn] 0.000572996535251
Value [qnco] 0.000572986840904
Profile [lbpr] 0.000569115761762
Female [fndg] 0.000567495754695
variables [qlco] 0.000566502243153
Recently [tmco] 0.000566335389995
Alternative [cnce] 0.000565472433177
Young [tmco] 0.000564006013816
Novel [tmco] 0.00056289729251
Normal [qlco] 0.000561528042013
Required [ftcn] 0.000560101415875
Beta-Blockers [phsu] 0.000557399291283
Area [geoa] 0.00055689041754
Relative [famg] 0.000554773408895
Prescription [hlca] 0.000554163721858
Calculated [ftcn] 0.000551043815054
Addition [ftcn] 0.000550607478525
M NOS [aapp, imft] 0.000548165193131
Dialysis [npop] 0.000546406571466
Challenge [clna] 0.000542213920967
Primary Prevention [topp] 0.00054157419071
side effects [ftcn] 0.000539377156865
Comorbidities [idcn] 0.00053855100518
Total Cholesterol [lbpr] 0.000538284741276
Cardiology [bmod] 0.000536821023802
Update [tmco] 0.000536224083671
Benefits [qnco] 0.000535147069961
Introduction [hlca] 0.000533458390844
Help [socb] 0.00053233941572
Percutaneous Coronary Intervention [topp] 0.000531926638967
Process [bpoc] 0.000531526690443
Myocardial [spco] 0.000530878375444
Address [inpr] 0.000530134423405
Secondary Prevention [topp] 0.000529953615564
cardiovascular risk factor [dsyn] 0.000529753612227
Knowledge [inpr] 0.000528968389775
Control Group [grup] 0.00052833878771
lowering [spco] 0.000527762193097
Complex [qlco] 0.00052770307002
Revascularisation [topp] 0.000527566186636
Revealed [qlco] 0.00052693631295
Congenital heart disease [cgab, dsyn] 0.000526553194701
GIVEN [cnce] 0.000526516632848
Initial [tmco] 0.000523902080658
toxicity [qlco] 0.00052359687486
Represent [acty] 0.000522058966497
Physicians [prog] 0.000517055868176
Action [ftcn] 0.000517013990684
Regression [patf] 0.000516909774066
statistically significant [qnco] 0.000516452889757
Order [inpr] 0.000515280233753
Antioxidant [phsu] 0.000514291883802
Variability [cnce] 0.00051242871879
LTD [ortf] 0.000511660428817
Single [popg] 0.000511619127663
Ischaemic [ftcn] 0.000510968604487
heart rate [clna] 0.000509076721807
Inflammation [patf] 0.000506578139919
Program [cnce] 0.000502940316133
Haemodialysis [topp] 0.000501376626524
Currently [tmco] 0.000500724186456
Region [geoa] 0.000499011823734
prognostic [inpr] 0.000497268672598
Hormone Therapy [topp] 0.000496852511777
Endothelial [tisu] 0.000496397955405
Advance [medd] 0.000495402872818
Multi [qnco] 0.000494294034884
prospective [resa] 0.00049362470489
Hospital [hcro, mnob] 0.000493612803587
Critical [qlco] 0.000493198629025
Proportion [qnco] 0.000489338897779
Regular [qlco] 0.000484373048961
Monitoring [hlca] 0.00048424675195
Dependent [qlco] 0.000482100372375
Eight [qnco] 0.000481271863458
Bleeding [patf] 0.000481017009625
Colorectal Cancer [neop] 0.000480601732321
Smoking [inbe] 0.000479837031912
Database [inpr] 0.000478891719252
Relevant [qlco] 0.000477269493144
High Density Lipoprotein Cholesterol [bacs, lipd] 0.000477242994985
Leading [tmco] 0.000477063606108
Review, Systematic [inpr] 0.000475306950091
Dietary [food] 0.000475031981717
Community [geoa] 0.000471290506721
Pre [tmco] 0.000470524137971
Estimate [qnco] 0.000468504107574
divided [ftcn] 0.000467546630706
criteria [inpr] 0.000467459826259
Very [qlco] 0.000467412878586
Activation [acty] 0.000467291731075
Derived [qlco] 0.000466929784308
Collected [idcn] 0.000464437469325
Link [inpr] 0.000462874226583
activity [dora] 0.00046114019574
Record [inpr] 0.000460376881246
Active [ftcn] 0.000458922993674
Clinic [hcro, mnob] 0.000457482246292
Short-term [tmco] 0.000456918259571
Diabetes Mellitus [dsyn] 0.000456746467556
Users [humn] 0.000456005894255
Flow [npop] 0.000455494078038
Concern [idcn] 0.000455266854746
topic9
treatment [ftcn] 0.0111478851366
P NOS [aapp, imft] 0.0104394132795
Study [mnob] 0.00744490158148
Group [idcn] 0.00655016017025
Women [popg] 0.00537718038304
Trial [resa] 0.00486868293843
Compared [acty] 0.00482876600609
Methods [inpr] 0.00466070407132
Increased [qnco] 0.00464673927765
Cardiovascular disease [dsyn] 0.00451283107072
CARDIOVASCULAR [bdsy] 0.00408192504837
Hypertension [dsyn] 0.00386111491066
Age [orga] 0.00384824806287
Mortality [qnco] 0.00357795528116
effects [qlco] 0.0034810848088
Conclusions [idcn] 0.0031716857734
included [ftcn] 0.0029900988862
Including [ftcn] 0.00292290231793
Based [ftcn] 0.00282475056972
Men [popg] 0.0028034085822
therapy [ftcn] 0.00264703497677
Diabetes [dsyn] 0.00252162626255
Survival [acty] 0.00249921466475
treated [topp] 0.00246953175876
Stroke [dsyn] 0.00244062439473
participants [popg] 0.0023980003159
months [tmco] 0.00237549609016
Heart [bpoc] 0.00226739324116
radiotherapy [inpr] 0.00212820256535
Quality [qlco] 0.00209455680536
Blood Pressure [orgf] 0.0020743566587
Suggest [idcn] 0.00206186829292
N NOS [aapp, imft] 0.00203898906558
Cardiac [bpoc] 0.00197322156294
coronary heart disease [dsyn] 0.00189237312054
Observed [ftcn] 0.0018703377633
Prevention [topp] 0.00186663502544
Health [idcn] 0.00185799338825
Levels [qlco] 0.00184922078692
Statins [orch, phsu] 0.00183220098686
risk factors [qnco] 0.00180519695339
effective [qlco] 0.00177986750316
Drug [phsu] 0.00170781430536
Efficacy [qlco] 0.00167885783737
Management [ocac] 0.00162435622387
Reduced [qlco] 0.00159003611131
reduction [npop] 0.00158193967085
Complications [patf] 0.00157816559391
Primary [qlco] 0.00154253399355
Assessed [acty] 0.0015146747837
Specific [qlco] 0.00149081273349
Reported [inpr] 0.00146690741564
Receive [qlco] 0.00146140979573
intervention [hlca] 0.00145145220339
Dose [qnco] 0.00144482574465
Performed [ftcn] 0.00143899863652
Present [qnco] 0.00140831551547
Evaluated [ftcn] 0.00139933506831
baseline [bodm] 0.00138478910482
Objective [inpr] 0.00138440547024
coronary artery disease [dsyn] 0.00137639361908
Children [aggp] 0.00137395422144
Received [qlco] 0.00136757340704
Main [qlco] 0.00136686841258
Reserve [acty] 0.00134851183378
Identified [qlco] 0.0013473347093
Care [acty] 0.00134296949993
Benefit [qnco] 0.00134232032724
Myocardial Infarction [dsyn] 0.00132961047502
Evaluate [ftcn] 0.00132496766278
placebo [topp] 0.00131636027529
Therapeutic [topp] 0.00129534589225
People [popg] 0.00128217490609
Survivors [podg] 0.00128156839564
Need [qlco] 0.00127397757739
Old [tmco] 0.00127229688507
Surgery [bmod] 0.00127068853293
Hormone replacement therapy [topp] 0.00126905978788
Induced [ftcn] 0.00125884467738
randomized [resa] 0.00123441187446
Lipid [lipd] 0.00123012641262
Published [ocac] 0.00122702465632
Combination [qlco] 0.00122136570487
Statin [orch, phsu] 0.00120961899007
Current [tmco] 0.00119026989083
Cases [ftcn] 0.00118926289602
Improved [qlco] 0.00118797735933
PREVENT [phsu] 0.00118757410613
Prognostic Factor [clna] 0.00118612123156
setting [ftcn] 0.00118250368926
Decreased [qnco] 0.00117955508039
cardiovascular events [fndg] 0.00117846292834
Conduct [inbe] 0.00117781243546
IMPACT [gngm] 0.0011712798792
Controlled [ftcn] 0.00117124768855
findings [ftcn] 0.00116925066717
considered [idcn] 0.0011619551197
Subject [grup] 0.00114777779208
Available [ftcn] 0.00114500428256
Breast Cancer [neop] 0.00114232297431
Adherence [ftcn] 0.00112235736178
Hazard Ratio [qnco] 0.00112189207273
Independent [idcn] 0.00112014080951
Design [acty] 0.00111811140341
Adjusted [ftcn] 0.00109774011542
interventions [hlca] 0.00109575236391
Approach [spco] 0.00109126334598
Decrease [qlco] 0.00109094544551
Severe [qlco] 0.0010880324308
Metabolic syndrome [dsyn] 0.00108001386668
Morbidity [qnco] 0.00107805454846
Improvement [cnce] 0.00107173896878
search [inpr] 0.00106466332245
Combined [qlco] 0.0010634610099
objectives [inpr] 0.00106022310221
Multiple [qnco] 0.00105730202279
Range [qnco] 0.001056836987
Chronic kidney disease [dsyn] 0.00105436219839
Authors [prog] 0.00103567425253
Parameters [fndg] 0.00102996415276
High Risk [qlco] 0.0010248425493
Often [tmco] 0.00102347493236
Atrial Fibrillation [patf] 0.00102269641513
Venous malformation [anab] 0.0010106536068
C-reactive protein [aapp, imft] 0.00100631429918
Sclerotherapy [topp] 0.00100510280774
Defined [cnce] 0.000999480573632
History [ocdi] 0.000998385783494
practice [menp] 0.00099547933398
Drugs [phsu] 0.000995017282847
Atherosclerosis [dsyn] 0.000990103111594
Five [qnco] 0.000986322051471
Well [qlco] 0.000985247786238
Radiation [npop] 0.000985172698361
Life [idcn] 0.000984991582782
Estrogen [horm, phsu, strd] 0.00098487465926
Androgen Deprivation Therapy [topp] 0.000982120410102
Medical [ftcn] 0.000973634890545
Required [ftcn] 0.000965061975185
Beta-Blockers [phsu] 0.000963025429006
national [inpr] 0.000959207036746
Heart failure [dsyn] 0.00095832986142
condition [dsyn] 0.000953767338521
experience [menp] 0.000953149619933
Elderly [popg] 0.000950468381935
strategies [menp] 0.000950158834828
symptoms [ftcn] 0.000947305373602
Target [ftcn] 0.000945212704072
vascular [bpoc] 0.000943125479986
Heart disease [dsyn] 0.000942907191844
Update [tmco] 0.000941815322536
Acute myocardial infarction [dsyn] 0.00093114021425
Support [medd] 0.000928354978977
postmenopausal [tmco] 0.000915387567121
Safety [hcpp] 0.000910859124166
Several [qnco] 0.000907217953342
Confidence Intervals [qnco] 0.00090665584634
Profile [lbpr] 0.000906020769697
GY [geoa] 0.000899901588891
Association [menp] 0.0008978753897
Following [tmco] 0.000894180039943
Score [qnco] 0.000886726643752
Odds Ratio [qnco] 0.000883716847782
Body Mass Index [diap] 0.000878602374672
Large [qnco] 0.000878342380226
In [qnco] 0.000859743589533
Medication [phsu] 0.000849549515224
Risks [qlco] 0.000845135310984
Likely [qlco] 0.000843226214807
Estimated [qnco] 0.000835901060873
acute [tmco] 0.000833578001887
deaths [orgf] 0.000831905950683
Status [qlco] 0.000830811786518
Additional [ftcn] 0.000811950865874
Mechanisms [ftcn] 0.000810966890343
Effectiveness [qlco] 0.000807913933514
Comparison [acty] 0.000806425519764
Cost Effectiveness [qnco] 0.00080281255951
Characteristics [qlco] 0.000802138806167
Aspirin [orch, phsu] 0.000800267460286
Diagnosed [fndg] 0.000797148425227
coronary [bpoc] 0.00079342455532
Obtained [ftcn] 0.000791558501068
function [phsf] 0.000788205746939
Events [evnt] 0.000786798068918
rats [mamm] 0.000785173010069
Last [qlco] 0.000783448443702
Evaluation [ftcn] 0.000782640863009
Purpose [ftcn] 0.000779748121862
ischaemic heart disease [dsyn] 0.000777348708929
Menopause [phsf] 0.00077582981952
Dyslipidaemia [dsyn] 0.000773452971165
Average [qnco] 0.000772367902167
chronic [tmco] 0.000770394148826
Surgical [hlca] 0.00077004238241
Select [acty] 0.000767772931746
Complex [qlco] 0.00076763469716
With [qlco] 0.000760747910066
Initial [tmco] 0.000755104540717
Female [fndg] 0.000752908780919
Young [tmco] 0.000751261093139
Make [ftcn] 0.000750764257428
LTD [ortf] 0.000750610316148
Assessment [hlca] 0.000749918667118
Comorbidities [idcn] 0.000744300355495
Information [idcn] 0.000741624678846
Known [qlco] 0.000739324672412
Measured [qlco] 0.000737816873754
Plasma [bdsu] 0.00073685622195
Aged [orga] 0.000736645806398
Small [qnco] 0.000735561099376
lesions [fndg] 0.000734784881017
investigated [ftcn] 0.00073201402572
Guidelines [inpr] 0.000731143504628
Agent [chvf] 0.000730477979974
Occurred [acty] 0.000723366811173
weeks [tmco] 0.000722220555392
Benefits [qnco] 0.000716311533657
Standard [qlco] 0.000712753442714
Knowledge [inpr] 0.000708368148837
Associations [menp] 0.000707975153008
Obesity [dsyn] 0.000705787485776
Appropriate [qlco] 0.000704950256132
Diabetes Mellitus [dsyn] 0.000704521680232
Take [hlca] 0.000702990394439
Treatments [topp] 0.000702717123614
Marker [clna] 0.000701877280271
Functional [ftcn] 0.000696542716795
lowering [spco] 0.000696428910822
Needed [qlco] 0.000694696972899
Smoking [inbe] 0.000681560037628
System [ftcn] 0.000681537265411
Exercise [dora] 0.000680978884476
Irradiation [npop] 0.000678618200279
Presented [idcn] 0.000677010233293
Contribute [acty] 0.000676551019235
Issue [fndg] 0.000673175680881
Hospital [hcro, mnob] 0.000672990357251
Local [spco] 0.000671611763462
Duration [tmco] 0.000669748743317
Values [qlco] 0.000667217812909
Damage [inpo] 0.000665647072723
Currently [tmco] 0.000663029548629
Hormone Therapy [topp] 0.000662627630535
APPEAR [qlco] 0.000662447400379
Measures [qnco] 0.000660653506895
recommendations [idcn] 0.000660604705099
Physical activity [dora] 0.000660188228995
Medications [phsu] 0.0006595614495
Burden [idcn] 0.000656912260522
PLAN [dsyn] 0.000653715984735
mmHg [qnco] 0.000653005202952
Drug Therapy [topp] 0.000652502814522
Sex [orgf] 0.000643254504738
Future [tmco] 0.000642759332708
Diseases [dsyn] 0.000642624062014
Adults [aggp] 0.000641873509677
Article [inpr] 0.000641394998881
Index [inpr] 0.000639012186772
Prostate Cancer [neop] 0.000637764992785
Physicians [prog] 0.000633225770153
Colorectal Cancer [neop] 0.000632983626194
Established [qlco] 0.000631107351318
Novel [tmco] 0.00062922589535
Limited [ftcn] 0.000623613727029
Reducing [qlco] 0.000622807389982
Ischaemic [ftcn] 0.00062155239011
Recommended [idcn] 0.000617168449297
Increasing [ftcn] 0.000616107996647
Relative [famg] 0.000615965224948
Concern [idcn] 0.000615722923142
Proportion [qnco] 0.000615026280632
Previous [tmco] 0.000611409038953
hypertensive [fndg] 0.000606365820547
statistically significant [qnco] 0.000606018277542
Report [inpr] 0.000604501500197
Post [tmco] 0.000602594998696
Primary Prevention [topp] 0.000601679829429
Response [orga] 0.00060098879514
Regression [patf] 0.000600742624924
Single [popg] 0.00059938262635
Doses [qnco] 0.000599322345749
reviewed [inpr] 0.000597710949341
Alone [qnco] 0.000595714817485
Searched [acty] 0.000595582777962
Secondary Prevention [topp] 0.000593441760602
Endothelial [tisu] 0.000592384905573
Measure [qnco] 0.000585965631788
Ratio [qnco] 0.000585653287741
adverse events [fndg] 0.0005847383108
Registry [inpr] 0.000583906814137
???lead [elii, hops] 0.000581316420123
strategy [menp] 0.000581003350097
Relationship [qlco] 0.00057963425879
secondary [neop] 0.00057919206892
Various [irda] 0.000578647700134
Long [qlco] 0.000575980462886
Of [spco] 0.000573228333202
mg% [qnco] 0.000571384362224
Oral [spco] 0.00057011626624
Affect [menp] 0.000569992938043
Meta-Analysis [inpr] 0.000569363162473
Hospitalization [hlca] 0.000568490232785
Central [spco] 0.000567734156407
Approaches [spco] 0.00056720165955
Leading [tmco] 0.000566713913816
Eight [qnco] 0.00056020667177
Imaging [diap] 0.000558684354769
days [tmco] 0.000558067305906
Examined [fndg] 0.000557193392735
Challenge [clna] 0.000556390077186
Arterial [bpoc] 0.000555482842852
Relevant [qlco] 0.000554258389603
procedures [inpr] 0.000553681100927
cardiovascular risk factor [dsyn] 0.000552630096771
Cardiovascular Diseases [dsyn] 0.000548090087311
GIVEN [cnce] 0.000546315165701
Guide [prog] 0.000545032581592
Cardiology [bmod] 0.00054431576181
Six [qnco] 0.000543224385638
Depression [mobd] 0.000543010648608
Extracted [topp] 0.000539835300951
investigate [ftcn] 0.000539542754302
Antioxidant [phsu] 0.000538839550305
Calculated [ftcn] 0.000538188382849
H+ [elii] 0.000533171777635
High dose [qnco] 0.000529923030868
Questionnaire [inpr] 0.00052932302244
Clinic [hcro, mnob] 0.000527074022789
Activation [acty] 0.000527068374274
Database [inpr] 0.000525371107731
Value [qnco] 0.000523621235267
Control Group [grup] 0.000522946584023
mg dl [qnco] 0.000521248898059
radiation therapy [inpr] 0.000520856819898
Literature [inpr] 0.000518253446708
Address [inpr] 0.000516719079187
M NOS [aapp, imft] 0.000516026300597
society [orgt] 0.000513982430412
Advanced [qlco] 0.000513570638436
Myocardial [spco] 0.000512021912565
Multi [qnco] 0.000511617827454
Revealed [qlco] 0.000511557554595
Recently [tmco] 0.000511396403815
Provided [acty] 0.000510946830442
Community [geoa] 0.000508636184557
Dependent [qlco] 0.000507982047543
Prescription [hlca] 0.000504041737426
Program [cnce] 0.00050379034416
Systolic blood pressure [clna] 0.000499619111307
Understanding [menp] 0.000498924089745
patient care [hlca] 0.000498528625023
prescribed [hlca] 0.00049559979174
progression [patf] 0.000495009584508
Daily [tmco] 0.000493180371625
prospective [resa] 0.000492243981752
Part [spco] 0.000489789467289
Countries [geoa] 0.000488691920301
Exposure NOS [inpo] 0.000488203420849
Haemodialysis [topp] 0.000486835500734
Moderate [qlco] 0.000485022174553
Play [dora] 0.000484842276355
Action [ftcn] 0.000483892445945
Alternative [cnce] 0.000483162043014
Vascular Malformations [anab] 0.000482254242202
Bias [idcn] 0.000481891212164
Collected [idcn] 0.000480148920944
surveillance [ftcn] 0.000480074576868
Altered [ftcn] 0.000476788320958
R- [spco] 0.000476652329691
free [ftcn] 0.000476519277771
Out [spco] 0.000476370677602
Life Style [socb] 0.000476058691358
Died [orgf] 0.000474597559494
Symptomatic [ftcn] 0.00047449216443
Beta [plnt] 0.000473951805236
Direct [qlco] 0.000472561841048
Area [geoa] 0.000471686895118
Optimal [qlco] 0.000470389138521
Dialysis [npop] 0.000468183370055
Chemotherapy [topp] 0.000467206982371
General Population [popg] 0.00046717663953
Seven [qnco] 0.000466213216368
prognostic [inpr] 0.000465892519317
Help [socb] 0.000465137022726
Conventional [qlco] 0.000464078332528
Data Collection [resa] 0.000461649368671
Correlated [qlco] 0.000461489643415
Link [inpr] 0.000460171623126
Represent [acty] 0.000460007343594
Order [inpr] 0.000459526714369
Total Cholesterol [lbpr] 0.000458439075174
Addition [ftcn] 0.000455803958775
Gender [orga] 0.000455148694218
Prostate [bpoc] 0.000454871111658
Stable [qlco] 0.00045457144054
Cumulative [qlco] 0.000452828886732
diabetic [fndg] 0.000452795603753
Niacin [orch, phsu, vita] 0.000452452535135
Congenital heart disease [cgab, dsyn] 0.000451651780366
